Prepared for:
Health Canada
Prepared by:
Leger
Ce rapport est aussi disponible en français
Contract number: HT372-214310/001/CY
POR #034-21
Awarded 2022-06-16
Contract Value (incl. HST): $224,759.27
Delivery Date: 2022-08-02
Leger
507 Place d'Armes, Suite 700
Montréal, Québec
G1R 2K2
Phone: 514-982-2464
Fax: 514-987-1960
For more information on this report, please contact Health Canada at: hc.cpab.por-rop.dgcap.sc@canada.ca
Final Report
Prepared for Health Canada
Supplier Name: Leger Marketing Inc.
August 2022
This public opinion research report presents the technical aspects of a tracking survey online conducted by Leger Marketing Inc. on behalf of Health Canada as well as qualitative findings report that provides insight into the eight focus groups that were conducted in June and July 2022. The research was conducted with Canadians aged 18 and over.
Cette publication est aussi disponible en français sous le titre : Étude concernant le point de vue des Canadiens sur la COVID-19.
This publication may be reproduced for non-commercial purposes only. Prior written permission must be obtained from Health Canada. For more information on this report, please contact Health Canada at hc.cpab.por-rop.dgcap.sc@canada.ca or at:
Health Canada, CPAB
200 Eglantine Driveway, Tunney's Pasture
Jeanne Mance Building, AL 1915C
Ottawa, Ontario K1A 0K9
Catalogue Number:
H14-389/1-2022E-PDF
International Standard Book Number (ISBN):
978-0-660-45564-8
Related publications (registration number: POR 034-21):
Étude concernant le point de vue des Canadiens sur la COVID-19 2021-2022
Catalogue Number (Final Report, French):
H14-389/1-2022F-PDF
ISBN:
978-0-660-45565-5
Leger is pleased to present the Government of Canada, Health Canada (HC) and the Public Health Agency of Canada (PHAC) with this report on the methodology used for this quantitative and qualitative study on health-related public opinion during the COVID-19 pandemic.
This report was prepared by Leger who was contracted by Health Canada (contract number HT372-214310/001/CY awarded June 16, 2022).
As part of their mandate to promote and protect Canadians' health as well as respond to public health emergencies, Health Canada and the Public Health Agency of Canada needed to gain a solid understanding of Canadians' level of awareness, knowledge, concerns, behaviours and opinions on specific COVID-19 related issues, as well as vaccines more broadly. This research provided HC and PHAC essential health-specific information to support their ongoing public health response and communications.
To that end, HC and PHAC implemented a study with multiple survey waves combined with focus groups to provide qualitative information. This project made it possible to survey the opinions of the Canadian population and measure the evolution of behaviours several times over the course of a few months.
The research allowed the Government of Canada to develop and refine communication activities to meet the specific needs of Canadians with timely, up-to-date, easily understood information based on the current perceptions of Canadians in the requisite COVID-19 areas and vaccines more broadly.
General objectives were established for all seven waves of the study (six quantitative waves and one qualitative). In addition, specific objectives for each wave were also established. The specific objectives of each wave are mentioned in the methodology section.
The general objectives were to understand Canadians' level of awareness, knowledge, concerns, behaviours and opinions on specific COVID-19 issues such as, but not limited to:
To achieve the study's objectives, a research plan based on a hybrid method, with qualitative and quantitative components, was developed. The two phases of the research were conducted in parallel: one phase being independent of the results of the other.
For the quantitative portion, eight initial waves of web surveys were conducted as part of this project during 2020-2021. Information regarding those waves is available in the following report: COVID-19 Tracking Survey on Canadians' Views 2020-2021 (Catalogue Number: H14-389/2021E-PDF). This report covers waves 9 to 14 only.
The quantitative part of this study was conducted through a web-based survey of the Canadian population aged 18 and over who can speak English or French. The respondents were randomly selected through the Leo panel, Leger's panel.
Six waves of the study were conducted for the second portion of the research project. Details on methodology for each wave are provided in this methodological report.
Wave | Target Audience | Fieldwork |
---|---|---|
Wave 9 | 3,000 Canadians 18+ with an oversample of Black and Indigenous respondents. | November 23, 2021 to December 8, 2021 |
Wave 10 | 1,000 Canadians 18+ | February 7-14, 2022 |
Wave 11 | 1,000 Canadians 18+ | February 22, 2022 to March 6, 2022 |
Wave 12 | 1,000 Canadians 18+ | March 8-16, 2022 |
Wave 13 | 3,000 Canadians 18+ with an oversample of Black and Indigenous respondents. | April 6-23, 2022 |
Wave 14 | 3,000 Canadians 18+ with an oversample of Black and Indigenous respondents. | June 21 to July 8, 2022 |
The results of this survey are not statistically projectable to the target population, because the sampling method used does not ensure that the sample represents the target population with a known margin of sampling error. Reported percentages are not generalizable to any group other than the sample studied, and therefore no formal statistical inferences can be drawn between the sample results and the broader target population it may be intended to reflect. Survey data is weighted to ensure that they replicate what the latest census would indicate in the composition of the adult population of Canada. Details regarding the weighting procedures and participation rate can be found in Appendix A.
Leger conducted a series of eight online discussion sessions with French and English speaking Canadians of 18 to 34 years of age, French and English speaking Canadians of 35 to 60 years of age, and French and English speaking parents.
Conducting the discussion sessions online offered the opportunity to regroup people from all regions in Canada. Five sessions were held in English and three were held in French. For each online discussion session, ten participants were recruited by our professional recruiters. A total of 64 recruits participated in the online discussion sessions. All participants in each discussion session received an honorarium of $135. All groups were scheduled to be held on June 20, 21 or 22, 2022. However, due to technical difficulties, two groups had to be rescheduled in the last week of June and one in July. Each session lasted approximately 120 minutes. Every session was recorded for analysis purposes.
The recruitment and discussion guides can be found in Appendix F, G and H respectively.
Locations and dates
Groups were held in the following regions on the dates specified in Table 3.
GR | Region | Recruits | Participants | Target | Time | Language | Date |
---|---|---|---|---|---|---|---|
1 | Ontario | 10 | 8 | Young adults (18-34) | 5pm | English | June 20th, 2022 |
2 | BC, Prairies, Territories | 10 | 9 | Young adults (18-34) | 5pm | English | July 6th, 2022 (originally scheduled on June 20th, 2022) |
3 | Québec, New-Brunswick | 10 | 10 | Young adults (18-34) | 5pm | French | June 20th, 2022 |
4 | BC, Prairies, Territories | 10 | 8 | Adults (35-60) | 5pm | English | June 21st, 2022 |
5 | Ontario | 10 | 9 | Adults (35-60) | 7pm | English | June 21st, 2022 |
6 | Québec, New-Brunswick | 10 | 8 | Adults (35-60) | 5pm | French | June 29th, 2022 (originally scheduled on June 20th, 2022) |
7 | BC, Prairies, Ontario | 10 | 3 | Parents | 5pm | English | June 22nd, 2022 |
8 | Québec, New-Brunswick | 10 | 9 | Parents | 5pm | French | June 21st, 2022 |
Total | 80 | 64 |
The opinions and observations expressed in this document do not reflect those of the Government of Canada, Health Canada (HC) or the Public Health Agency of Canada (PHAC). This report was compiled by Leger based on research conducted specifically for this project.
Qualitative research is designed to reveal a rich range of opinions and interpretations rather than to measure what percentage of the target population holds a given opinion. These results must not be used to estimate the numeric proportion or number of individuals in the population who hold a particular opinion because they are not statistically projectable.
I hereby certify, as chief agent of Leger, that the deliverables are in full compliance with the neutrality requirements of the Policy on Communications and Federal Identity and the Directive on the Management of Communications—Appendix C (Appendix C: Mandatory Procedures for Public Opinion Research).
Specifically, the deliverables do not include information on electoral voting intentions, political party preferences, party positions, or the assessment of the performance of a political party or its leaders.
Signed by:
Christian Bourque
Executive Vice President and Associate
Leger
507 Place d'Armes, Suite 700
Montréal, Quebec
H2Y 2W8
cbourque@leger360.com
This quantitative portion of the study was conducted through a web-based survey of the Canadian population aged 18 and over who can speak English or French. The respondents were randomly selected through the Leo panel, Leger's panel of Canadian Internet users comprising nearly half a million Internet users.
Six waves of studies were conducted for this research project. Details for each wave are provided in the following sections.
For the ninth wave, a sample of 3,002 respondents (2,278 from the general population, 452 Black respondents and 272 Indigenous respondents) representative of the Canadian population completed the survey. Fieldwork for this survey took place from November 23, 2021, to December 8, 2021.
The objectives of the ninth survey wave were to assess Canadians' behaviour at this point in the pandemic and evaluate their opinions on different topics related to COVID-19. More questions about vaccines and booster shots were asked in this wave.
The questionnaire for the ninth wave can be found in Appendix B.
For the ninth wave, the objective was to have a representative sample of the Canadian population aged 18 and over, but also to have a better understanding of the opinions of Black and Indigenous respondents. To do so, the following regional distribution and the following over samples was established:
Region |
ATL |
QC |
ON |
MB/SK |
AB |
BC |
TERR. |
Black (oversample) |
Indigenous (oversample) |
---|---|---|---|---|---|---|---|---|---|
# of Respondents |
225 |
490 |
755 |
315 |
250 |
355 |
10 |
400 |
200 |
The actual numbers achieved for the different quotas can be found in appendix A.
As for any general population sample derived from a national survey, the final results were weighted by region, age, gender, language, education levels, presence or children in the household, immigration status, and ethnicity.
To validate the programming of the questionnaire, a pretest in both official languages was conducted before the data collection. The following table shows the details of the pretest.
Wave 9 |
|
---|---|
Date of the pretest |
November 23, 2021 |
Number of complete surveys |
36 (21 in English and 15 in French) |
Average length during pretest |
10.55 min |
As no problems were detected during the pretest, data collection went forward.
The following table details the collection dates and the number of respondents and recontacts for this wave.
Wave 9 |
|
---|---|
Start of data collection |
November 23, 2021 |
End of data collection |
December 8, 2021 |
Invitations sent |
25,536 |
Number of reminders sent |
4 |
Number of completed interviews |
3,002 |
Survey Length (Average) |
13.55 min |
Below is the calculation of the participation rate for the ninth wave. The participation rate is calculated using the following formula: Participation rate / response rate = R ÷ (U + IS + R). The table below provides details of the calculation.
Invalid cases |
0 |
Invitations mistakenly sent to people who did not qualify for the study |
0 |
Incomplete or missing email addresses |
0 |
Unresolved (U) |
22,190 |
Email invitations that bounced back |
28 |
Email invitations unanswered |
22,162 |
In-scope non-responding units (IS) |
184 |
Non-response from eligible respondents |
0 |
Respondent refusals |
0 |
Language problem |
0 |
Selected respondent not available (illness; leave of absence; vacation; other) |
0 |
Early break-offs |
184 |
Responding units (R) |
3,048 |
Completed surveys disqualified – quota filled |
0 |
Completed surveys disqualified for other reasons |
46 |
Completed interviews |
3,002 |
POTENTIALLY ELIGIBLE (U+IS+R) |
25,423 |
Participation rate |
12% |
For the tenth wave, a sample of 1,005 respondents representative of the Canadian population aged 18 and over completed the survey. Fieldwork for this survey took place from February 7 to February 14, 2022.
The objectives of the tenth survey wave were to assess Canadians' behaviour at this point in the pandemic and evaluate their opinions on different topics related to COVID-19 and their practice of public health measures. Questions about vaccines, booster shots and children vaccination were also asked in this wave.
The questionnaire for this wave can be found in Appendix C.
For the tenth wave, the objective was to have a representative sample of the Canadian population. To do so, the following regional distribution was established:
Region |
ATL |
QC |
ON |
MB/SK |
AB |
BC |
TERR. |
---|---|---|---|---|---|---|---|
# of Respondents |
100 |
200 |
300 |
145 |
100 |
150 |
5 |
The numbers achieved for the different quotas can be found in appendix A.
For the tenth wave, final results were weighted by region, age, gender, language, education levels and presence of children in the household.
To validate the programming of the questionnaire, a pretest in both official languages was conducted before the data collection. The following table shows the details of the pretest.
Wave 10 |
|
Date of the pretest |
February 7, 2022 |
Number of complete surveys |
28 (16 in English and 12 in French) |
Average length during pretest |
8 min |
As no problems were detected during the pretest, data collection went forward.
The following table details the collection dates and the number of respondents and recontacts for this wave.
Wave 10 |
|
---|---|
Start of data collection |
February 7, 2022 |
End of data collection |
February 14, 2022 |
Invitations sent |
7,459 |
Number of reminders sent |
0 |
Number of completed interviews |
1,005 |
Survey Length (Average) |
15.11 min |
Below is the calculation of the participation rate for the tenth wave. The participation rate is calculated using the following formula: Participation rate / response rate = R ÷ (U + IS + R). The table below provides details of the calculation.
Invalid cases |
0 |
Invitations mistakenly sent to people who did not qualify for the study |
0 |
Incomplete or missing email addresses |
0 |
Unresolved (U) |
6,393 |
Email invitations that bounced back |
33 |
Email invitations unanswered |
6,360 |
In-scope non-responding units (IS) |
45 |
Non-response from eligible respondents |
0 |
Respondent refusals |
0 |
Language problem |
0 |
Selected respondent not available (illness; leave of absence; vacation; other) |
0 |
Early break-offs |
45 |
Responding units (R) |
1,023 |
Completed surveys disqualified – quota filled |
0 |
Completed surveys disqualified for other reasons |
18 |
Completed interviews |
1,005 |
POTENTIALLY ELIGIBLE (U+IS+R) |
7,461 |
Participation rate |
13,7% |
For the eleventh wave, a sample of 1,001 respondents representative of the Canadian population aged 18 and over completed the survey. Fieldwork for this survey took place from February 22 to March 06, 2022.
The objectives of this wave were the same as those of the tenth wave since the same questionnaire was used. The questionnaire for this wave can be found in Appendix C.
For the eleventh wave, the objective was to have a representative sample of the Canadian population. To do so, the following regional distribution was established:
Region |
ATL |
QC |
ON |
MB/SK |
AB |
BC |
TERR. |
---|---|---|---|---|---|---|---|
# of Respondents |
100 |
200 |
300 |
145 |
100 |
150 |
5 |
The numbers achieved for the different quotas can be found in appendix A.
For the eleventh wave, final results were weighted by region, age, gender, language, education levels and presence of children in the household.
To validate the programming of the questionnaire, a pretest in both official languages was conducted before the data collection. The following table shows the details of the pretest.
Wave 11 |
|
---|---|
Date of the pretest |
February 22, 2022 |
Number of complete surveys |
34 (24 in English and 10 in French) |
Average length during pretest |
8.57 min |
As no problems were detected during the pretest, data collection went forward.
The following table details the collection dates and the number of respondents and recontacts for this wave.
Wave 11 |
|
---|---|
Start of data collection |
February 232, 2022 |
End of data collection |
March 6, 2022 |
Invitations sent |
6,423 |
Number of reminders sent |
2 |
Number of completed interviews |
1,001 |
Survey Length (Average) |
12.29 min |
Below is the calculation of the participation rate for the eleventh wave. The participation rate is calculated using the following formula: Participation rate / response rate = R ÷ (U + IS + R). The table below provides details of the calculation.
Invalid cases |
0 |
Invitations mistakenly sent to people who did not qualify for the study |
0 |
Incomplete or missing email addresses |
0 |
Unresolved (U) |
5,343 |
Email invitations that bounced back |
52 |
Email invitations unanswered |
5,291 |
In-scope non-responding units (IS) |
44 |
Non-response from eligible respondents |
0 |
Respondent refusals |
0 |
Language problem |
0 |
Selected respondent not available (illness; leave of absence; vacation; other) |
0 |
Early break-offs |
44 |
Responding units (R) |
1,020 |
Completed surveys disqualified – quota filled |
0 |
Completed surveys disqualified for other reasons |
19 |
Completed interviews |
1,001 |
POTENTIALLY ELIGIBLE (U+IS+R) |
6,407 |
Participation rate |
15,9% |
For the twelfth wave, a sample of 1,000 respondents representative of the Canadian population aged 18 and over completed the survey. Fieldwork for this survey took place from March 8 to March 16, 2022.
The objectives of this wave were the same as those of the tenth and eleventh waves since the same questionnaire was used. The questionnaire for this wave can be found in Appendix C.
For the twelfth wave, the objective was to have a representative sample of the Canadian population. To do so, the following regional distribution was established:
Region |
ATL |
QC |
ON |
MB/SK |
AB |
BC |
TERR. |
---|---|---|---|---|---|---|---|
# of Respondents |
100 |
200 |
300 |
145 |
100 |
150 |
5 |
The numbers achieved for the different quotas can be found in appendix A.
For the twelfth wave, final results were weighted by region, age, gender, language, education levels and presence of children in the household.
To validate the programming of the questionnaire, a pretest in both official languages was conducted before the data collection. The following table shows the details of the pretest.
Wave 12 |
|
---|---|
Date of the pretest |
March 8, 2022 |
Number of complete surveys |
34 (20 in English and 14 in French) |
Average length during pretest |
9.36min |
As no problems were detected during the pretest, data collection went forward.
The following table details the collection dates and the number of respondents and recontacts for this wave.
Wave 12 |
|
---|---|
Start of data collection |
March 8, 2022 |
End of data collection |
March 16, 2022 |
Invitations sent |
7,038 |
Number of reminders sent |
2 |
Number of completed interviews |
1,000 |
Survey Length (Average) |
13.03 min |
Below is the calculation of the participation rate for the twelfth wave. The participation rate is calculated using the following formula: Participation rate / response rate = R ÷ (U + IS + R). The table below provides details of the calculation.
Invalid cases |
0 |
Invitations mistakenly sent to people who did not qualify for the study |
0 |
Incomplete or missing email addresses |
0 |
Unresolved (U) |
6,057 |
Email invitations that bounced back |
85 |
Email invitations unanswered |
5,972 |
In-scope non-responding units (IS) |
36 |
Non-response from eligible respondents |
0 |
Respondent refusals |
0 |
Language problem |
0 |
Selected respondent not available (illness; leave of absence; vacation; other) |
0 |
Early break-offs |
36 |
Responding units (R) |
1,013 |
Completed surveys disqualified – quota filled |
0 |
Completed surveys disqualified for other reasons |
13 |
Completed interviews |
1,000 |
POTENTIALLY ELIGIBLE (U+IS+R) |
7,106 |
Participation rate |
14,25% |
For the thirteenth wave, a sample of 3,013 respondents (2,286 from the general population, 451 Black respondents and 276 Indigenous respondents) representative of the Canadian population aged 18 and over completed the survey. Fieldwork for this survey took place from April 6 to April 23, 2022.
The objectives of the thirteenth survey wave were to assess Canadians' behaviour at this point in the pandemic and evaluate their opinions on different topics related to COVID-19. Questions were asked about vaccines in general and the resumption of missed vaccines due to the pandemic.
The questionnaire for the thirteenth wave can be found in Appendix D.
For the thirteenth wave, the objective was to have a representative sample of the Canadian population, but also to have a better understanding of the opinions of Black and Indigenous respondents. To do so, the following regional distribution and the following over samples was established:
Region |
ATL |
QC |
ON |
MB/SK |
AB |
BC |
TERR. |
Black (oversample) |
Indigenous (oversample) |
---|---|---|---|---|---|---|---|---|---|
# of Respondents |
225 |
490 |
755 |
315 |
250 |
355 |
10 |
400 |
200 |
The numbers achieved for the different quotas can be found in appendix A.
For the thirteenth wave, final results were weighted by region, age, gender, language, education levels, presence of children in the household, immigration status and ethnicity.
To validate the programming of the questionnaire, a pretest in both official languages was conducted before the data collection. The following table shows the details of the pretest.
Wave 13 |
|
---|---|
Date of the pretest |
April 6, 2022 |
Number of complete surveys |
35 (20 in English and 15 in French) |
Average length during pretest |
8.53 min |
As no problems were detected during the pretest, data collection went forward.
The following table details the collection dates and the number of respondents and recontacts for this wave.
Wave 13 |
|
---|---|
Start of data collection |
April 6, 2022 |
End of data collection |
April 23, 2022 |
Invitations sent |
25,962 |
Number of reminders sent |
2 |
Number of completed interviews |
3,013 |
Survey Length (Average) |
14.41 min |
Below is the calculation of the participation rate for the thirteenth wave. The participation rate is calculated using the following formula: Participation rate / response rate = R ÷ (U + IS + R). The table below provides details of the calculation.
Invalid cases |
0 |
Invitations mistakenly sent to people who did not qualify for the study |
0 |
Incomplete or missing email addresses |
0 |
Unresolved (U) |
24,979 |
Email invitations that bounced back |
83 |
Email invitations unanswered |
24,896 |
In-scope non-responding units (IS) |
119 |
Non-response from eligible respondents |
0 |
Respondent refusals |
0 |
Language problem |
0 |
Selected respondent not available (illness; leave of absence; vacation; other) |
0 |
Early break-offs |
119 |
Responding units (R) |
3,057 |
Completed surveys disqualified – quota filled |
0 |
Completed surveys disqualified for other reasons |
44 |
Completed interviews |
3,013 |
POTENTIALLY ELIGIBLE (U+IS+R) |
28,155 |
Participation rate |
10,85% |
For the fourteenth wave, a sample of 3,009 respondents (2,284 from the general population, 447 Black respondents and 278 Indigenous respondents) representative of the Canadian population aged 18 and over completed the survey. Fieldwork for this survey took place from June 21, 2022 to July 8, 2022.
The objectives of the fourteenth survey wave were to assess Canadians' behaviour at this point in the pandemic and evaluate their opinions on different topics related to COVID-19. Questions were asked about vaccines in general and the resumption of missed vaccines due to the pandemic.
The questionnaire for the fourteenth wave can be found in Appendix E.
For the fourteenth wave, the objective was to have a representative sample of the Canadian population, but also to have a better understanding of the opinions of Black and Indigenous respondents. To do so, the following regional distribution and the following over samples was established:
Region |
ATL |
QC |
ON |
MB/SK |
AB |
BC |
TERR. |
Black (oversample) |
Indigenous (oversample) |
---|---|---|---|---|---|---|---|---|---|
# of Respondents |
225 |
490 |
755 |
315 |
250 |
355 |
10 |
400 |
200 |
The numbers achieved for the different quotas can be found in appendix A.
For the fourteenth wave, final results were weighted by region, age, gender, language, education levels, presence of children in the household, immigration status, and ethnicity.
To validate the programming of the questionnaire, a pretest in both official languages was conducted before the data collection. The following table shows the details of the pretest.
Wave 14 |
|
---|---|
Date of the pretest |
June 21st, 2022 |
Number of complete surveys |
39 (20 in English and 19 in French) |
Average length during pretest |
9.37 min |
As no problems were detected during the pretest, data collection went forward.
The following table details the collection dates and the number of respondents.
Wave 14 |
|
---|---|
Start of data collection |
June 21, 2022 |
End of data collection |
July 8, 2022 |
Invitations sent |
37,004 |
Number of reminders sent |
2 |
Number of completed interviews |
3,009 |
Survey Length (Average) |
15.56 min |
Below is the calculation of the participation rate for the fourteenth wave. The participation rate is calculated using the following formula: Participation rate / response rate = R ÷ (U + IS + R). The table below provides details of the calculation.
Invalid cases |
0 |
Invitations mistakenly sent to people who did not qualify for the study |
0 |
Incomplete or missing email addresses |
0 |
Unresolved (U) |
32,274 |
Email invitations that bounced back |
24 |
Email invitations unanswered |
32,250 |
In-scope non-responding units (IS) |
200 |
Non-response from eligible respondents |
0 |
Respondent refusals |
0 |
Language problem |
0 |
Selected respondent not available (illness; leave of absence; vacation; other) |
0 |
Early break-offs |
200 |
Responding units (R) |
3,069 |
Completed surveys disqualified – quota filled |
0 |
Completed surveys disqualified for other reasons |
60 |
Completed interviews |
3,009 |
POTENTIALLY ELIGIBLE (U+IS+R) |
35,543 |
Participation rate |
8,63% |
Overall, the general feeling among participants was that currently COVID-19 does not pose as big of a threat to individuals as it did during the previous waves and the first variants. Participants considered that two years of pandemic coupled with the vaccine advances, along with new strains that are less deadly (even though they are more contagious) have contributed to reducing their worries towards COVID-19. Several participants also mentioned having caught the virus, which has also helped reduce their fear, as they now know what to expect. Most participants had mild cases of COVID-19, with a few reporting more severe symptoms.
Considering that the COVID-19 virus is still present but less dangerous, some participants mentioned that the virus entered or will enter the endemic phase, and comparisons to the flu/influenza have been drawn. Just like the flu, participants felt like while it posed a risk for vulnerable individuals, it was generally harmless to healthy ones. Parents did not set themselves apart from the rest of the participants in terms of feelings towards COVID-19, as they did not feel it posed a serious threat to their children.
In spite of that, participants do still feel that some risks exist, especially when it comes to catching the virus themselves. However, they felt confident about their recovery, as most of them were vaccinated with at least 2 doses. Those who were not vaccinated were trustful of their immune systems to get through the sickness. The participants who mentioned being more vulnerable because of specific health conditions expressed feeling more risks related to catching the virus.
Participants were generally more worried about spreading the virus to their peers (family, friends…) rather than getting it themselves. They were confident in being able to recover if they were to be infected but did not want to spread it to their social circles, especially individuals who had compromised immune systems or were more vulnerable to the virus.
Considering that COVID-19 is still around and still poses some risks, participants felt that governments should draw from the past two years or so of the pandemic and the learnings it has brought to put in place new ways and measures to handle the public health situation. A return to previous restrictive measures such as lockdowns and curfews was seen as highly unlikely. And if they were to happen, participants expressed low buy-in as they were not convinced of the efficacy of such measures. Therefore, participants who were living or working with vulnerable people, and those who were themselves more vulnerable, were more cautious in terms of public health measures. Some of them expressed that they thought the measures were lifted too soon, and others mentioned feeling like they were being left aside from the "return to normal" plans. Vulnerable individuals felt like the lifting of measures might have been too drastic as there were no measures in place to protect their health, leaving it to them to self-isolate and avoid close contact with others, which made them feel a division between them and the rest of society.
Finally, participants were torn regarding the meaning of "being up to date" with their vaccines. Participants mentioned the phrase could have different meanings depending on the context. While some thought it meant having the first two doses, others thought the booster was also included. Others had a more general definition like "being up to date with public health recommendations", or "whatever the government allows you to have", or "getting the most recent shot possible".
A majority of participants were vaccinated against COVID-19. Be it their own personal choice or a constrained choice to avoid negative repercussions of being unvaccinated, several reasons and incentives were mentioned by participants. The following list details the most common reasons given by participants as to why they got themselves or their children vaccinated.
Some other reasons that were mentioned by participants in favor of vaccination include the following:
A majority of participants declared turning to acquaintances who work in the public health or medical field for information and advice. While official public health and government websites were still among the most common sources of information, participants have brought up not knowing what to do or believe because of the rapidly changing and sometimes contradictory measures and information communicated by public health officials, which might in turn have led to them turning to acquaintances in the field to try to get more reliable information.
While government and public health officials' legitimacy has slowly eroded over the course of the pandemic, Canadians tried to bridge to gap by turning to acquaintances in the field who were seen as more reliable.
Word-of-mouth in general was also a main source of information, as people also tended to turn to their families and friends in general to make up their own opinion regarding public health measures and vaccines. Hearing about peers who suffered strong side effects from getting vaccinated or boosted was a strong deterrent for some participants. On the other hand, hearing about peers who suffered strong symptoms from COVID-19 infection was also a strong incentive to get vaccinated.
Finally, some participants mentioned doing research on the internet (with no further precision) and on official public health websites, and others mentioned not doing any research as they felt that the vaccination decision was just common sense.
Canadians' attitudes towards booster doses were mainly informed by their opinions towards COVID-19 in general. Considering that most participants felt that the worst of the COVID-19 pandemic had passed, they mentioned the lack of incentives for them to get their booster doses. While several of them had gotten their third dose (first booster), most of them mentioned adopting a "wait and see" approach and preferred seeing how the pandemic situation evolves before making up their minds regarding getting any further booster shots. The current situation was seen as not threatening enough to get the booster doses. Less severe COVID-19 strains and lifting of public health measures are the main reasons participants would not get their booster doses.
In addition to that, some participants mentioned their worries regarding the short interval between booster doses and the number of booster doses that have been reached so far. Comparisons with the flu vaccine boosters were drawn. Some participants felt like booster dose rollout might be too intensive.
Considering that some participants mentioned only getting vaccinated because they were obligated (whether for work, or to get back to "normal" life and be able to travel, go to restaurants, etc.), they expressed their unwillingness to get booster doses, unless mandatory (i.e., to have an up-to-date vaccination status).
A minority of participants mentioned wanting to get their booster shots when eligible.
There were mixed attitudes among groups of parents regarding booster doses. Some parents stated that they would actively make sure that their children would get the boosters when they would become available for their age groups, others stated that two doses seemed sufficient and that they would wait to see how the situation evolves before deciding whether or not to get booster doses. Some parents also expressed concerns relating to the frequency of booster doses and some stated that they would not get the boosters unless more efficient versions were conceived which would be resistant against future variants.
While a few participants mentioned they had never heard of long COVID, a majority were familiar with it. The most known symptoms were the prolonged fatigue, the loss of taste and smell, and respiratory issues. A few participants mentioned that long COVID played a role in their decision-making process regarding vaccination, but the majority stated it did not affect their decision to get vaccinated.
Antiviral treatments were not very known among participants. Therefore, they did not have an impact on participants' decision to get vaccinated.
Due to the lack of testing and studies on the effects of the vaccine on children, parents were not trustful of the vaccine. Considering the current situation, most of them prefer the "wait and see" approach for themselves. One participant mentioned they would rather test the vaccine on themselves before getting it for their children. But when it came to older children (aged 12 or older), parents included them in the discussion and let them make up their own mind regarding vaccination.
A majority of participants agreed with the statement "I am comfortable with the possibility of becoming infected with COVID-19 and not getting vaccinated.", while some agreed with the statement "It's important to continue to protect myself from serious illness from COVID-19 by getting vaccinated, including getting booster doses". Participants who agreed with the first statement were therefore much less anxious towards COVID-19 infection and illness and seemed ready to be infected as they perceive the virus to be less dangerous.
Participants were torn regarding whether the decision to get vaccinated is an individual decision or a contribution to the public good. They acknowledged the importance of doing one's role to protect the community against the virus, but they highlighted the fact that individuals should still have their say on getting vaccinated or not and that there are other ways of protecting their community (i.e., social distancing, staying home when sick, etc.).
The pandemic did not seem to have an impact on participants' views regarding vaccines at large. Participants made a clear distinction between the COVID-19 vaccine and so-called "routine vaccines" that are administered mainly during childhood. The perceived legitimacy of "routine vaccines" is much higher than that of the COVID-19 vaccine, as the former are seen as much safer considering how long they have been around. Parents therefore mentioned still planning on vaccinating their children and keeping them up to date with their routine vaccines. Only one participant mentioned they would think differently about routine vaccines from now on. Other than that, participants actually noted that the pandemic had a positive effect on their knowledge of vaccines and how they are developed and manufactured.
However, parents were unsure about what routine vaccines their children received or had to receive. They strongly relied on their schools and family doctors to keep up with their vaccines.
Participants were dubious regarding the safety of COVID-19 vaccines. The main concern was how fast these vaccines were developed and put on the market. Long-term side effects that have yet to be studied were also an impacting factor. However, some participants stated their full confidence in public health institutions and scientists regarding vaccine safety. Participants acknowledged that while some risks or side effects might have not been discovered yet, they still trusted public health and health care experts. The perceived safety of the COVID-19 vaccines was also hindered by the short-term side effects some participants reported experiencing, that in some cases dissuaded them from getting booster doses. Finally, participants seemed attentive to word-of-mouth and hearsay about side effects of the vaccine. Some participants reported having heard of people having negative experiences with the vaccine, which contributed to shaping their own negative perception towards the vaccine and its safety.
Regarding vaccine effectiveness, participants had mixed perceptions. While some considered them effective because they prevent serious forms of the disease, others deemed them useless because they did not prevent infection and spreading of the virus. Most people however agreed that vaccines were effective in reducing the strain on the health care system.
The perceived effectiveness of booster doses was negatively influenced by the frequency at which they need to be administered: once again, participants compared the COVID-19 booster with the flu booster, as the latter only needs to be taken once a year. Mutations of the COVID-19 virus and the emergence of various strains that require new adjusted booster shots have contributed to weakening the perceived effectiveness of the booster shots.
For the reasons stated above, many participants expressed unwillingness to get new booster doses. Some mentioned they would only take them if they proved to be longer lasting and more efficient than current boosters.
While conspiratorial beliefs were rare among participants, some expressed their lack of understanding of boosters and shared incorrect and false information about the COVID-19 vaccine. Participants mentioned that if the vaccine effectively protects from the COVID-19 virus, then boosters should not be needed. It was also mentioned that they found it curious that vaccines are being recommended considering that the immune system is supposed to fight the virus after remembering it. Others mentioned anecdotal facts about vaccines at large, and a participant even mentioned that vaccines were just part of a fearmongering campaign strategy. Aside from these isolated beliefs, most participants stuck with the official information shared by official institutions regarding the vaccine situation, even though concerns were shared.
The participants generally mentioned having complied with official COVID-19 mandates when implemented by local authorities. They cited washing hands, practicing social distancing, wearing masks, and isolating when showing symptoms of illness as examples of measures they consistently complied with. However, some participants stated that not having the possibility to work from home or not having access to paid sick leave was a significant barrier to comply with self-isolation.
Many participants stated that although they were making efforts to follow the official public health guidelines, the rationale supporting the imposition of measures and restrictions gradually became less clear and coherent. Many participants indicated that the reasons given by their local authorities for implementing or lifting different measures were communicated very poorly, and that the variety of sources giving out different information, such as different institutions or levels of government, significantly added to the general uncertainty or confusion. Many respondents also expressed their feeling that the implementation or removal of sanitary measures was often based on political considerations rather than on science. Some of them stated that they no longer believed much of the information communicated by public institutions and governments, relying more on their own knowledge and research. Some participants suggested that a single, centralized source of reliable information concerning the pandemic situation and related measures would be beneficial for an improved understanding of the situation among the population. Overall, the general feeling among participants was that governments should leave room for individuals to make their own decisions to protect themselves and their peers as they see fit, rather than imposing measures that are often seen as incoherent.
A large proportion of participants agreed that some of the sanitary measures put in place since the beginning of the pandemic should be permanently adopted to prevent the spread of illnesses of all kinds. They cited wearing masks when necessary, practicing social distancing and isolating when feeling sick, along with more hand washing and better sanitization in general as behaviours that should be maintained beyond the context of the pandemic. However, many were opposed to going back to the imposition of such measures through government mandates. Many participants seemed to prefer a more individualistic approach to health measures in the future, arguing that individuals should be responsible for applying relevant sanitary measures or not based on their activities and their likeliness to put others at risk. Some participants also argued that vulnerable people should be responsible for protecting themselves from being infected with COVID-19. Other participants argued that while the application of sanitary measures should be left more to the discretion of individuals, special efforts and solidarity should be shown in order to protect vulnerable people.
A majority of participants indicated generally not wearing masks anymore now that they are no longer required, unless they are in presence of vulnerable people or in medical institutions. A few participants indicated that they still wear masks in grocery stores, public transit or when they are in crowded places. Many participants also indicated still wearing a mask when showing symptoms of illness or allergies. Very few participants noted that they were feeling judged while still wearing masks in public spaces. On the contrary, some participants mentioned that they were feeling judged if not wearing a mask when displaying symptoms such as a runny nose or sneezing. Some participants from parent groups indicated that their children did not have any issues with wearing masks at school, with the exception of having to wear them while doing sports or in gym class, when it got uncomfortable for the children to wear.
Most participants indicated that people should stay at home if showing symptoms of illnesses to prevent spreading COVID-19 and other illnesses. However, most participants also indicated that they would not necessarily stay at home if they only felt light symptoms, but that they would inform the people they would come in contact with about their symptoms ahead of meeting with them, to ensure that they are comfortable. Many of them agreed that showing two symptoms or more would prompt them to stay home. On the other hand, some participants indicated that not having the possibility to work from home or not having access to paid sick leave was a significant barrier to self-isolation. Those whose income depends on their physical presence at their workplace tended to say that only heavy symptoms significantly affecting their capacity to work would prompt them to stay home and self-isolate. Mixed answers came from groups of parents concerning which symptoms would incite them to leave their children at home, but often included a runny nose, heavy cough, sore throat and fever.
Many participants indicated that the pandemic had somewhat changed their habits when they are feeling sick. They mentioned being more cautious, tending to self-isolate more, communicating their symptoms to the people they would come in contact with and trying to significantly diminish their contacts with others, for example by ordering food instead of going out to the grocery store or to the restaurant.
Some young adults from the French-speaking group admitted that while they respected health mandates in public spaces, they often did not respect them in private. They admitted to reuniting with friends and family and indulging in social gatherings, including beyond curfew hours, when it was not allowed.
Many participants said that their mental health was affected on some level during the pandemic. The impact of the pandemic on mental health seemed to vary greatly depending on each person's living and working situation. Respondents who lived alone seemed to have felt a more negative impact on their mental health than those living with roommates, friends, their partner or with their family. Participants who had to work from home also appeared to be more negatively impacted by the pandemic in contrast to those who were essential workers, due to the lack of social interactions with their colleagues.
Many participants said that the uncertainty that surrounded the pandemic and related government mandates affected their mental health, because they had no indications of how long the situation would last and what impacts it might have on their lives. Respondents from Quebec highlighted the curfews imposed by the provincial government as some of the most difficult moments of the pandemic for their mental health. A few respondents also mentioned that the isolation resulting from the health crisis prompted them to seek professional help and medication.
While some participants indicated that they had the chance to keep working from home and have a steady income, a few mentioned that they lost significant income, which caused them to have severe anxiety. Some others indicated that the inability to practice their favourite sports had a negative impact on their mental health, while others mentioned that maintaining active habits and doing sport during the lockdowns significantly helped them stay positive and healthy.
The participants unanimously agreed that the lifting of restrictions directly played a role in improving their mental health. Of those who said that the pandemic had a negative impact on their mental health, some say that everything is now back to normal because of the restrictions being lifted. Some others say that although the easing of the restrictions significantly contributed to improving their mental state, they are still in the process of recovery.
While many parents said that their children did not experience particular mental health issues, others said that the lack of social interactions had a negative effect on their children's social development and mental health. Some parents also mentioned being worried about their child's development regarding socialisation. However, some of them mentioned that being all at home together enabled them to quickly notice when something was wrong with their children and to address it. Some parents also mentioned that they felt having lost precious time and opportunities for doing activities with their children because everything was closed and that they wouldn't necessarily have the chance to do it again in the future.
Message 1:
Option 1, English: A booster helps protect you against severe illness.
Option 1, French: Une dose de rappel vous protège contre les risques de maladie grave.
Option 2, English: Staying up-to-date with your COVID-19 vaccine helps protect you against severe illness.
Option 2, French: Rester à jour avec vos vaccins contre la COVID-19 contribue à vous protège contre les maladies graves.
The participants' feedback was relatively split between these two options. Those who preferred the first option mentioned that the term "booster", or "dose de rappel" in French, was more precise and specific as opposed to "staying up-to-date", or "rester à jour" in French. A majority of participants agreed on the fact that "staying up-to-date", or "rester à jour", was too vague and could lead to confusion. None of these options were significantly clearer or more motivating to the participants. Among groups of French-speakers, the wording of "maladies graves" raised questions and occasioned many negative comments. French-speaking participants stated that the message should be centred on COVID-19, as "maladies graves" seemed to refer to many different health issues beyond COVID-19, such as cancer, for example. There were no other differences of opinion between demographic groups.
Message 2:
English: Staying up-to-date with your COVID-19 vaccines helps protect you from getting really sick so you can get back to activities and everyday life more quickly if you do get infected.
French : En restant à jour avec vos vaccins contre la COVID-19, vous contribuez à vous protégez contre les maladies graves ce qui vous permettra de reprendre vos activités et votre vie quotidienne plus rapidement dans l'éventualité où vous seriez infecté.
This message was received quite negatively by the participants as no real positive arguments were put forward in favour of it. The message was generally not seen as motivational or meaningful, and many aspects of it raised questions. Many participants spontaneously mentioned the confusion produced by the message and the fact that it was too long, poorly worded, and might be more efficient if split into two separate sentences. Once again, the wording "staying up-to-date", or "en restant à jour" in French, proved to be problematic among many participants who did not agree on its meaning and highlighted that it could lead to confusion. Moreover, a few participants indicated that they did not consider this message to be particularly relevant since they felt that life already mostly returned to normal with the removal of most sanitary restrictions by public authorities. Some participants doubted the message's veracity because they did not feel like the vaccines against COVID-19 were all that effective and suggested that including more convincing facts into it would help take it more seriously. Some participants among French-speaking groups again raised the issue of the wording "maladies graves", which they felt was misleading. They mentioned that the current wording of the message led to the conclusion that the COVID-19 vaccine protects against other severe illnesses in addition to COVID-19, which is not the case. They suggested changing "maladies graves" for "conséquences graves" or "complications graves" explicitly related to COVID-19.
Message 3:
English: Staying up-to-date with your COVID-19 vaccines helps reduce the strain of COVID-19 for everyone, and on the health care system.
French : En restant à jour avec vos vaccins contre la COVID-19, vous contribuez à réduire la pression exercée par la COVID-19 sur la communauté et sur le système de santé.
Some participants agreed that this message was true, factual and quite clear. While a few participants appreciated the fact that the strain on the health care system was evoked, many others criticized the moralizing aspect of the message, feeling like the advertiser was trying to play on people's feelings of guilt. Many participants saw this message as a negative campaign playing on fear and indicated that such messages that try to put pressure on people to get vaccinated would likely prove to be counterproductive. Again, a few participants expressed doubts about the veracity of the message, questioning whether COVID-19 vaccines actually help reduce the strain on society and on the health care system. A few participants suggested to remove "for everyone", thus focusing the message on the negative impacts of COVID-19 on the health care system, which they seemed to feel would be more direct and more accurate than the current wording of the message. Positive reactions to this message were more common among groups of young adults. Participants from English-speaking groups warned that the use of the word "strain" in a message related to COVID-19 could cause some confusion since it is very often used to refer to "strains of the virus".
Message 4:
English: A booster dose of mRNA vaccines offers better protection against infection and severe disease, including recent variants like Omicron, than the first set of vaccines alone.
French : Comparativement à une série primaire, une dose de rappel d'un vaccin à ARNm offre une meilleure protection contre les infections et les maladies graves, y compris les variantes récentes comme Omicron.
Reactions to this message were generally negative. While some participants pointed to the reference to Omicron as relatable and easy to understand, many others thought that the message was too long and contained too many different elements. Some participants indicated that the wording "better protection" was too vague and should be explained better. Some respondents said that the message did not convey the impression of the booster providing a significant additional protection against the virus, while some others thought that the message was dismissive of protection provided by the two first doses of the COVID-19 vaccines. Many participants doubted that more technical terms such as mRNA would be understood by a large proportion of the population and suggested removing it. This fourth message seemed to cause confusion especially among French-speaking groups. Again, some francophone participants said that the reference to "infections et maladies graves" gave the impression that the message was about other diseases unrelated to COVID-19. The wording "formes graves de la COVID" was suggested to replace it. Many other participants among those groups indicated that the wording "série primaire" was not quite clear as it was not used much to refer to the first series of vaccines and could lead to confusion. They added that this message might be too technical and that it might raise many questions among the readers rather than provide answers and information. Some participants from young adult groups also felt like the message diminished or discredited the efficiency of the initial doses of the vaccine.
Message 5:
English: Even if you've completed your primary series, protection will decrease over time. A booster dose is important to get because it increases the immune response and helps improve protection against severe outcomes by 90% or more.
French: Même si vous avez reçu votre série primaire, la protection diminue avec le temps. Il est important de recevoir une dose de rappel, car elle augmente la réponse immunitaire et contribue à améliorer de 90 % ou plus la protection contre les conséquences graves.
This message was the most widely appreciated among the participants. They generally found it clear, factual, and welcomed the addition of a percentage as giving a sense of trust. The use of "severe outcomes", or "consequences graves" in French, was also more appreciated than the references to "serious illness", or "maladies graves" in French, seen in previous messages. However, many participants criticized the wording of this message as giving the sense of a sales-like slogan trying to convince them to get the vaccine. The use of "primary series", or "série primaire" in French, was widely criticized by the participants as being unusual and confusing. Participants from English-speaking groups suggested changing the wording, some mentioning the previously used wording "first set of vaccines", or simply referring to "first and second doses" which they thought was clearer. Participants from French-speaking groups mentioned removing "série primaire" but did not suggest alternatives. While some participants mentioned that the message's length would prompt them not to read it, others praised its clarity and indicated appreciating the message despite it being a bit long. Some participants added that the message would gain from being more concise.
Message 6:
English: Some preliminary findings suggest that vaccination may potentially help reduce the risk of developing post COVID-19 condition, if you are infected.
French: Les premières données probantes suggèrent que la vaccination peut contribuer à réduire le risque de développer le syndrome post-COVID-19 si une personne est infectée.
This message was one of the least appreciated by the participants. They almost unanimously denounced its lack of clarity and the uncertainty conveyed by it. This message was seen as a succession of unproven, uncertain and unclear information. The participants expressed their feeling that there was a lack of information in this message or that it was trying to hide something. As such, this message created doubt, suspicion and mistrust among the participants, which seemed to achieve the opposite of motivating them to get vaccinated. Some participants suggested that the studies used to support the facts being brought forward in the message should be made explicit, and that their exact sources should be provided to enhance the transparency and credibility of the message. Some respondents indicated being somewhat confused or never having the term "post COVID-19 condition", or "syndrome post-COVID-19". Some suggested changing it to "long COVID", or "COVID longue". There were no clear differences in opinion between demographic groups regarding this message.
Message 7:
English: You should get vaccinated even if you've been previously infected or think you may have been infected. While a previous COVID-19 infection can provide some protection, up-to-date vaccination—including a booster dose―is recommended to provide longer-lasting, more effective protection against severe outcomes.
French : Il est recommandé de vous faire vacciner même si vous avez déjà été infecté ou si vous pensez avoir été infecté. Bien qu'une infection antérieure à la COVID-19 peut apporter une certaine protection, rester à jour avec ses vaccins - y compris une dose de rappel - est recommandée pour apporter une protection meilleure et plus durable contre les conséquences graves.
This message was one of the most appreciated by the participants. It was perceived as clear and well structured, while also providing an interesting flow of information for the participants. The tone of the message was also appreciated by the participants. The fact that it contains a recommendation rather than an attempt to impose vaccination was perceived positively. Most participants also thought the message was clear and easy to understand. On the other hand, some participants indicated that the message was too long, and many admitted that they would probably not read it completely if they were to come across it in their everyday life. There also were mixed reactions to the addition of "including a booster dose", or "y compris une dose de rappel" in French, within the message. Some participants appreciated the precision it added to the message, while others thought it was not needed and made the message longer than needed.
The message was not received as positively among young adults. Many of them thought the message was too long and criticized its moralizing aspect. Some of them also indicated that beginning the message with "you should" would prompt them to disregard its content. Groups of parents seem to have appreciated this message more than other groups, indicating that it was effective and had more of a conversational feel, which made it easier to understand and more relatable. However, they mentioned that making it more concise would probably improve it.
Message 8:
English: We all have a role to play in keeping ourselves, our families and our communities healthy.
French : Nous avons tous un rôle à jouer pour maintenir notre santé, celle de nos familles et de nos communautés.
In general, most participants rather appreciated this message and its softer, collectivist tone, but many also questioned its relevance. The vast majority of them found it to be self-evident and many wondered whether this message was about COVID-19 or if it was a more general message. Many participants saw this message as unnecessary because it did not seem clearly related to COVID-19. There were no noteworthy differences in opinion regarding this message between demographic groups.
Quantitative research was conducted through online surveys, using Computer Aided Web Interviewing (CAWI) technology. Leger adheres to the most stringent guidelines for quantitative research. The survey instrument was compliant with the Standards of Conduct of Government of Canada Public Opinion Research. Respondents were assured of the voluntary, confidential, and anonymous nature of this research. As with all research conducted by Leger, all information that could allow for the identification of participants was removed from the data, in accordance with the Privacy Act.
A panel-based Internet survey with a sample of Canadian adults from the general population was made randomly from the Leo online panel.
Leger owns and operates an Internet panel of more than 400,000 Canadians from coast to coast. An Internet panel is made up of web users profiled on different sociodemographic variables. The majority of Leger's panel members (61%) have been recruited randomly over the phone over the past decade, making it highly similar to the actual Canadian population on many demographic characteristics. Respondents earn points for each survey they complete and can redeem their points for rewards.
The questionnaires for this project, as well as the material to be tested, were provided by Health Canada. The data collection has been conducted in accordance with the Standards for the Conduct of Government of Canada Public Opinion Research—Series A—Fieldwork and Data Tabulation for Online Surveys.
In addition to pre-testing to ensure the quality of programming, Leger has a process in place to ensure the quality of the responses given by respondents. Leger also has implemented a series of validation questions to ensure the reliability of the results in each survey. The process is outlined as follows:
The research team supervises programming and ensures that each question, response category, and skip patterns have been properly entered and this, even after this information has been verified by two separate programmers and a data analyst, to check for consistency.
In broad terms, Leger's methodological approach for an online survey includes the following steps:
Highly trained programmers, assisted by experienced data analysts, program each survey in CAWI then perform thorough testing to ensure that no stone is left unturned.
Upon completion of data collection for online surveys, Leger's data analysts and data processing department will clean the data thoroughly, ensuring that:
The data is checked and cleaned after the pretest, after the first night of fieldwork, and at project completion. All numbers are double-checked, and any outliers are also double-checked to ensure the data has been entered accurately in the first place.
All projects have a team of coders assigned to edit, clean, and develop meaningful codes for the answers to open-ended questions. Leger develops the codebook and code open-ended questions accordingly. The same codebook is used for each wave (if applicable). New codes may be created if a specific answer becomes more prominent and the client approves. All data from open-ended questions is checked by different coders to ensure data is accurate and correctly coded. No coded data are going to be processed by our statisticians until a second team of coders has reviewed and approved of all code lists. The codebook is also subject to approval by the project authority.
With Centralus, our proprietary software, project managers can check on frequencies, the number of completes, quotas (if any), and the participation rate at any time during the field. Centralus is most often used internally by research teams as a rapid checker tool for frequencies check and quotas. This "real-time" management tool allows for any issues to be quickly flagged and corrected as well as in managing survey invitations to be sent to reach set quotas for the research. Centralus is also capable of delivering standard frequencies to clients in real-time via the Internet (with a password-protected site). Centralus is an additional project tracking tool in addition to Decipher and both platforms are used by the research teams.
Our Leo technical assistance team is available 7 days a week from 8 am to 9 pm ET to answer any inquiry on the part of survey respondents or help fix technical problems. If a question is submitted by phone or email outside of office hours, the technical assistance team will respond first thing the following morning. Our Leo team comprises individuals who can answer questions in both official languages at all times. This is the Leger advantage.
Wave 9:
The tables below present the geographic distribution of respondents, their gender, age, language, level of education, presence of children in household, ethnicity and immigration status before and after weighting for the ninth wave.
There is no evidence from the data that having achieved a different distribution prior to weighting would have significantly changed the results for this study. The relatively small weight sizes and differences in responses between various subgroups suggest that data quality was not affected. The weight that was applied corrected the initial imbalance for data analysis purposes and no further manipulations were necessary.
Label |
Unweighted |
Weighted |
---|---|---|
Region |
||
British Columbia and Yukon |
402 |
410 |
Alberta and Northwest Territories |
304 |
337 |
Manitoba, Saskatchewan and Nunavut |
365 |
194 |
Ontario |
991 |
1,152 |
Quebec |
691 |
704 |
Atlantic |
249 |
204 |
Gender |
||
Men |
1,367 |
1,438 |
Women |
1,619 |
1,544 |
Age |
||
Between 18 and 34 |
827 |
813 |
Between 35 and 54 |
1,134 |
1,031 |
55 years old and over |
1,041 |
1,158 |
Language |
||
English |
2,027 |
1,929 |
French |
660 |
681 |
Other |
293 |
362 |
Level of education |
||
High school or less |
686 |
870 |
College |
954 |
1,256 |
University |
1,330 |
817 |
Presence of children in the household |
||
Yes |
798 |
819 |
No |
2,193 |
2,171 |
Immigrant status |
||
Born in Canada |
2,326 |
2,345 |
Born outside Canada |
676 |
657 |
Ethnicity |
||
Indigenous |
272 |
144 |
Black |
452 |
110 |
Weighting factors for wave 9
Some subgroups are sometimes under or overrepresented in a sample compared to the general population. The weighting of a sample makes it possible to correct those differences. The weighting factors are therefore the weight given to each respondent corresponding to a subgroup of the sample. For the ninth wave, results were weighted by region, gender, age, language, level of education, immigration status, ethnicity and presence of children in the household.
Label |
Weight |
---|---|
British Columbia and Male and Between 18 and 24 |
0,7200 |
British Columbia and Male and Between 25 and 34 |
1,0900 |
British Columbia and Male and Between 35 and 44 |
1,0200 |
British Columbia and Male and Between 45 and 54 |
1,1700 |
British Columbia and Male and Between 55 and 64 |
1,6700 |
British Columbia and Male and 65 + |
0,9100 |
British Columbia and Female and Between 18 and 24 |
0,6900 |
British Columbia and Female and Between 25 and 34 |
1,1100 |
British Columbia and Female and Between 35 and 44 |
1,0800 |
British Columbia and Female and Between 45 and 54 |
1,2500 |
British Columbia and Female and Between 55 and 64 |
1,7800 |
British Columbia and Female and 65 + |
1,0900 |
Alberta and Male and Between Between 18 and 44 |
2,8700 |
Alberta and Male and Between 45 and 54 |
0,9900 |
Alberta and Male and Between 55 and 64 |
1,2000 |
Alberta and Male and 65 + |
0,5200 |
Alberta and Female and Between 18 and 24 |
0,6200 |
Alberta and Female and Between 25 and 34 |
1,1400 |
Alberta and Female and Between 35 and 44 |
1,0400 |
Alberta and Female and Between 45 and 54 |
0,9800 |
Alberta and Female and Between 55 + |
1,8500 |
Manitoba/Saskatchewan and Male and Between 18 and 34 |
0,9800 |
Manitoba/Saskatchewan and Male and Between 35 and 44 |
0,5300 |
Manitoba/Saskatchewan and Male and Between 45 and 54 |
0,5400 |
Manitoba/Saskatchewan and Male and Between 55 and 64 |
0,7500 |
Manitoba/Saskatchewan and Male and 65+ |
0,3900 |
Manitoba/Saskatchewan and Female and Between 18 and 24 |
0,3800 |
Manitoba/Saskatchewan and Female and Between 25 and 34 |
0,5800 |
Manitoba/Saskatchewan and Female and Between 35 and 44 |
0,5300 |
Manitoba/Saskatchewan and Female and Between 45 and 54 |
0,5500 |
Manitoba/Saskatchewan and Female and Between 55 and 64 |
0,7700 |
Manitoba/Saskatchewan and Female and 65+ |
0,5100 |
Ontario and Male and Between 18 and 34 |
5,3100 |
Ontario and Male and Between 35 and 44 |
2,9300 |
Ontario and Male and Between 45 and 54 |
3,4600 |
Ontario and Male and Between 55 and 64 |
4,4300 |
Ontario and Male and 65+ |
2,3700 |
Ontario and Female and Between 18 and 24 |
2,1400 |
Ontario and Female and Between 25 and 34 |
3,1500 |
Ontario and Female and Between 35 and 44 |
3,1800 |
Ontario and Female and Between 45 and 54 |
3,6500 |
Ontario and Female and Between 55 + |
7,7800 |
Quebec and Male and Between 18 and 34 |
3,0300 |
Quebec and Male and Between 35 and 44 |
1,8900 |
Quebec and Male and Between 45 and 54 |
2,0300 |
Quebec and Male and Between 55 and 64 |
2,9500 |
Quebec and Male and 65+ |
1,5400 |
Quebec and Female and Between 18 and 24 |
1,2000 |
Quebec and Female and Between 25 and 34 |
1,8100 |
Quebec and Female and Between 35 and 44 |
1,8800 |
Quebec and Female and Between 45 and 54 |
2,0300 |
Quebec and Female and Between 55 + |
5,1200 |
ATL and Male and Between 18 and 34 |
0,7800 |
ATL and Male and Between 35 and 44 |
0,4900 |
ATL and Male and Between 45 and 54 |
0,6100 |
ATL and Male and Between 55 and 64 |
0,9300 |
ATL and Male and 65+ |
0,4700 |
ATL and Female and Between 18 and 24 |
0,3300 |
ATL and Female and Between 25 and 34 |
0,4700 |
ATL and Female and Between 35 and 44 |
0,5300 |
ATL and Female and Between 45 and 54 |
0,6500 |
ATL and Female and Between 55 and 64 |
0,9800 |
ATL and Female and 65+ |
0,5800 |
Total |
100% |
Label |
Weight |
---|---|
British Columbia (Vancouver CMA) |
7,1900 |
British Columbia (Other) |
6,3700 |
Alberta (Edmonton CMA) |
11,2200 |
Ontario (Tor CMA) |
16,9300 |
Ontario (Other) |
21,4600 |
Quebec (Mtl CMA) |
11,7300 |
Quebec (Qc CMA) |
2,3500 |
Quebec (Other) |
9,3800 |
Other |
13,3700 |
Total |
100% |
Label |
Weight |
---|---|
Quebec AND French |
18,0900 |
Quebec AND not French |
5,3700 |
Rest of Canada AND French |
2,7100 |
Rest of Canada AND not French |
73,8300 |
Total |
100% |
Label |
Weight |
---|---|
Not University |
72,8000 |
University |
27,2000 |
Total |
100% |
Label |
Weight |
---|---|
Yes |
27,67000 |
No |
72,33000 |
Total |
100% |
Label |
Weight |
---|---|
Born in Canada |
78,1000 |
Born outside Canada |
21,9000 |
Total |
100% |
Label |
Weight |
---|---|
Indigenous |
4,81000 |
South Asian |
5,53000 |
Black |
3,45000 |
Other |
86,21000 |
Total |
100% |
Wave 10:
The tables below present the geographic distribution of respondents, their gender, age, language, level of education, the presence of children in the household before and after weighting for the tenth wave.
Label |
Unweighted |
Weighted |
---|---|---|
Region |
||
British Columbia and Yukon |
156 |
136 |
Alberta and Northwest Territories |
100 |
113 |
Manitoba, Saskatchewan and Nunavut |
145 |
66 |
Ontario |
303 |
386 |
Quebec |
201 |
236 |
Atlantic |
100 |
69 |
Gender |
||
Men |
508 |
488 |
Women |
491 |
510 |
Age |
||
Between 18 and 34 |
250 |
263 |
Between 35 and 54 |
376 |
353 |
55+ |
379 |
388 |
Language |
||
English |
714 |
701 |
French |
198 |
209 |
Other |
90 |
92 |
Level of education |
||
High school or less |
244 |
338 |
College |
274 |
374 |
University |
480 |
278 |
Presence of children in the household |
||
Yes |
244 |
273 |
No |
757 |
727 |
Weighting factors for wave 10
Results for the tenth wave were weighted by region, gender, age, language and level of education and presence of children in the household.
Label |
Weight |
---|---|
British Columbia and Male and Between 18 and 24 |
0,7200 |
British Columbia and Male and Between 25 and 34 |
1,0900 |
British Columbia and Male and Between 35 and 44 |
1,0200 |
British Columbia and Male and Between 45 and 54 |
1,1700 |
British Columbia and Male and Between 55 and 64 |
1,1700 |
British Columbia and Male and 65 + |
1,4100 |
British Columbia and Female and Between 18 and 24 |
0,6800 |
British Columbia and Female and Between 25 and 34 |
1,1100 |
British Columbia and Female and Between 35 and 44 |
1,0800 |
British Columbia and Female and Between 45 and 54 |
1,2500 |
British Columbia and Female and Between 55 and 64 |
1,2500 |
British Columbia and Female and 65 + |
1,6200 |
Alberta and Male and Between 18 and 24 & Alberta and Male and Between 25 and 34 |
1,8100 |
Alberta and Male and Between 35 and 44 |
1,0600 |
Alberta and Male and Between 45 and 54 |
0,9900 |
Alberta and Male and Between 55 and 64 |
0,9000 |
Alberta and Male and 65 + |
0,8300 |
Alberta and Female and Between 18 and 24 |
0,6200 |
Alberta and Female and Between 25 and 34 |
1,1400 |
Alberta and Female and Between 35 and 44 |
1,0400 |
Alberta and Female and Between 45 and 54 |
0,9800 |
Alberta and Female and Between 55 and 64 |
0,8900 |
Alberta and Female and 65 + |
0,9600 |
Manitoba/Saskatchewan and Male and Between 18 and 24 |
0,4000 |
Manitoba/Saskatchewan and Male and Between 25 and 34 |
0,5800 |
Manitoba/Saskatchewan and Male and Between 35 and 44 |
0,5300 |
Manitoba/Saskatchewan and Male and Between 45 and 54 |
0,5500 |
Manitoba/Saskatchewan and Male and Between 55 and 64 |
0,5500 |
Manitoba/Saskatchewan and Male and 65+ |
0,5900 |
Manitoba/Saskatchewan and Female and Between 18 and 24 |
0,3800 |
Manitoba/Saskatchewan and Female and Between 25 and 34 |
0,5800 |
Manitoba/Saskatchewan and Female and Between 35 and 44 |
0,5300 |
Manitoba/Saskatchewan and Female and Between 45 and 54 |
0,5500 |
Manitoba/Saskatchewan and Female and Between 55 and 64 |
0,5600 |
Manitoba/Saskatchewan and Female and 65+ |
0,7200 |
Ontario and Male and Between 18 and 24 |
2,2300 |
Ontario and Male and Between 25 and 34 |
3,0600 |
Ontario and Male and Between 35 and 44 |
2,9200 |
Ontario and Male and Between 45 and 54 |
3,4600 |
Ontario and Male and Between 55 and 64 |
3,1600 |
Ontario and Male and 65+ |
3,6300 |
Ontario and Female and Between 18 and 24 |
2,1200 |
Ontario and Female and Between 25 and 34 & Ontario and Female and Between 35 and 44 |
6,3400 |
Ontario and Female and Between 45 and 54 |
3,6500 |
Ontario and Female and Between 55 and 64 |
3,3800 |
Ontario and Female and 65+ |
4,4100 |
Quebec and Male and Between 18 and 24 |
1,2100 |
Quebec and Male and Between 25 and 34 |
1,8000 |
Quebec and Male and Between 35 and 44 |
1,8900 |
Quebec and Male and Between 45 and 54 |
2,0300 |
Quebec and Male and Between 55 and 64 |
2,1100 |
Quebec and Male and 65+ |
2,3900 |
Quebec and Female and Between 18 and 24 |
1,1800 |
Quebec and Female and Between 25 and 34 |
1,8100 |
Quebec and Female and Between 35 and 44 |
1,8900 |
Quebec and Female and Between 45 and 54 |
2,0300 |
Quebec and Female and Between 55 and 64 |
2,1700 |
Quebec and Female and 65+ |
2,9500 |
ATL and Male and Between 18 and 24 |
0,3400 |
ATL and Male and Between 25 and 34 |
0,4600 |
ATL and Male and Between 35 and 44 |
0,4900 |
ATL and Male and Between 45 and 54 |
0,6100 |
ATL and Male and Between 55 and 64 |
0,6500 |
ATL and Male and 65+ |
0,7600 |
ATL and Female and Between 18 and 24 |
0,3300 |
ATL and Female and Between 25 and 34 |
0,4700 |
ATL and Female and Between 35 and 44 |
0,5300 |
ATL and Female and Between 45 and 54 |
0,6500 |
ATL and Female and Between 55 and 64 |
0,6900 |
ATL and Female and 65+ |
0,8900 |
Total |
100% |
Label |
Weight |
British Columbia (Vancouver RMR) |
7,2000 |
British Columbia (Other) |
6,3700 |
Alberta (Calgary RMR) |
3,8400 |
Alberta (Edmonton RMR) |
3,6500 |
Alberta (Other) |
3,7300 |
Saskatchewan |
3,0100 |
Manitoba |
3,5100 |
Ontario (Tor RMR) |
16,9200 |
Ontario (Other) |
21,4400 |
Quebec (Mtl RMR) |
11,7300 |
Quebec (Qc RMR) |
2,3500 |
Quebec (Other) |
9,3800 |
New-Brunswick |
2,2000 |
Nova Scotia |
2,7200 |
Prince Edward Island |
0,4100 |
Newfoundland |
1,5400 |
Total |
100% |
Label |
Weight |
---|---|
Yes |
27,67000 |
No |
72,33000 |
Total |
100% |
Label |
Weight |
French ROC |
2,7100 |
French QC |
18,0900 |
Not French ROC |
73,8300 |
Not French QC |
5,3700 |
Total |
100% |
Label |
Weight |
---|---|
Not University |
72,3300 |
University ROC |
21,81 |
University QC |
5,86 |
Total |
100% |
Wave 11:
The tables below present the geographic distribution of respondents, their gender, age, language, level of education and presence of children in the household before and after weighting.
Label |
Unweighted |
Weighted |
---|---|---|
Region |
||
British Columbia and Yukon |
156 |
136 |
Alberta and Northwest Territories |
100 |
112 |
Manitoba, Saskatchewan and Nunavut |
145 |
65 |
Ontario |
300 |
384 |
Quebec |
200 |
235 |
Atlantic |
100 |
69 |
Gender |
||
Men |
468 |
486 |
Women |
523 |
507 |
Age |
||
Between 18 and 34 |
241 |
273 |
Between 35 and 54 |
379 |
341 |
55 years old and over |
381 |
387 |
Language |
||
English |
708 |
692 |
French |
198 |
208 |
Other |
92 |
99 |
Level of education |
||
High school or less |
210 |
273 |
College |
336 |
440 |
University |
446 |
277 |
Presence of children in the household |
||
Yes |
237 |
270 |
No |
759 |
724 |
Weighting factors for wave 11
For the eleventh wave, results were weighted by region, gender, age, language, level of education, and presence of children in the household.
Label |
Weight |
---|---|
British Columbia and Male and Between 18 and 24 |
0,7200 |
British Columbia and Male and Between 25 and 34 |
1,0900 |
British Columbia and Male and Between 35 and 44 |
1,0200 |
British Columbia and Male and Between 45 and 54 |
1,1700 |
British Columbia and Male and Between 55 and 64 |
1,1700 |
British Columbia and Male and 65 + |
1,4100 |
British Columbia and Female and Between 18 and 24 |
0,6800 |
British Columbia and Female and Between 25 and 34 |
1,1100 |
British Columbia and Female and Between 35 and 44 |
1,0800 |
British Columbia and Female and Between 45 and 54 |
1,2500 |
British Columbia and Female and Between 55 and 64 |
1,2500 |
British Columbia and Female and 65 + |
1,6200 |
Alberta and Male and Between 18 and 24 |
0,6500 |
Alberta and Male and Between 25 and 34 |
1,1600 |
Alberta and Male and Between 35 and 44 |
1,0600 |
Alberta and Male and Between 45 and 54 |
0,9900 |
Alberta and Male and Between 55 and 64 |
0,9000 |
Alberta and Male and 65 + |
0,8300 |
Alberta and Female and Between 18 and 24 |
0,6200 |
Alberta and Female and Between 25 and 34 |
1,1400 |
Alberta and Female and Between 35 and 44 |
1,0400 |
Alberta and Female and Between 45 and 54 |
0,9800 |
Alberta and Female and Between 55 and 64 |
0,8900 |
Alberta and Female and 65 + |
0,9600 |
Manitoba/Saskatchewan and Male and Between 18 and 24 |
0,4000 |
Manitoba/Saskatchewan and Male and Between 25 and 34 |
0,5800 |
Manitoba/Saskatchewan and Male and Between 35 and 44 |
0,5300 |
Manitoba/Saskatchewan and Male and Between 45 and 54 |
0,5500 |
Manitoba/Saskatchewan and Male and Between 55 and 64 |
0,5500 |
Manitoba/Saskatchewan and Male and 65+ |
0,5900 |
Manitoba/Saskatchewan and Female and Between 18 and 24 |
0,3800 |
Manitoba/Saskatchewan and Female and Between 25 and 34 |
0,5800 |
Manitoba/Saskatchewan and Female and Between 35 and 44 |
0,5300 |
Manitoba/Saskatchewan and Female and Between 45 and 54 |
0,5500 |
Manitoba/Saskatchewan and Female and Between 55 and 64 |
0,5600 |
Manitoba/Saskatchewan and Female and 65+ |
0,7200 |
Ontario and Male and Between 18 and 24 & Ontario and Male and Between 25 and 34 |
5,2900 |
Ontario and Male and Between 35 and 44 |
2,9200 |
Ontario and Male and Between 45 and 54 |
3,4600 |
Ontario and Male and Between 55 and 64 |
3,1600 |
Ontario and Male and 65+ |
3,6300 |
Ontario and Female and Between 18 and 24 |
2,1200 |
Ontario and Female and Between 25 and 34 |
3,1500 |
Ontario and Female and Between 35 and 44 |
3,1900 |
Ontario and Female and Between 45 and 54 |
3,6500 |
Ontario and Female and Between 55 and 64 |
3,3800 |
Ontario and Female and 65+ |
4,4100 |
Quebec and Male and Between 18 and 24 |
1,2100 |
Quebec and Male and Between 25 and 34 |
1,8000 |
Quebec and Male and Between 35 and 44 |
1,8900 |
Quebec and Male and Between 45 and 54 |
2,0300 |
Quebec and Male and Between 55 and 64 |
2,1100 |
Quebec and Male and 65+ |
2,3900 |
Quebec and Female and Between 18 and 24 |
1,1800 |
Quebec and Female and Between 25 and 34 |
1,8100 |
Quebec and Female and Between 35 and 44 |
1,8900 |
Quebec and Female and Between 45 and 54 |
2,0300 |
Quebec and Female and Between 55 and 64 |
2,1700 |
Quebec and Female and 65+ |
2,9500 |
ATL and Male and Between 18 and 24 |
0,3400 |
ATL and Male and Between 25 and 34 |
0,4600 |
ATL and Male and Between 35 and 44 |
0,4900 |
ATL and Male and Between 45 and 54 |
0,6100 |
ATL and Male and Between 55 and 64 |
0,6500 |
ATL and Male and 65+ |
0,7600 |
ATL and Female and Between 18 and 24 |
0,3300 |
ATL and Female and Between 25 and 34 |
0,4700 |
ATL and Female and Between 35 and 44 |
0,5300 |
ATL and Female and Between 45 and 54 |
0,6500 |
ATL and Female and Between 55 and 64 |
0,6900 |
ATL and Female and 65+ |
0,8900 |
Total |
100% |
Label |
Weight |
---|---|
British Columbia (Vancouver RMR) |
7,2000 |
British Columbia (Other) |
6,3700 |
Alberta (Calgary RMR) |
3,8400 |
Alberta (Edmonton RMR) |
3,6500 |
Alberta (Other) |
3,7300 |
Saskatchewan |
3,0100 |
Manitoba |
3,5100 |
Ontario (Tor RMR) |
16,9200 |
Ontario (Other) |
21,4400 |
Quebec (Mtl RMR) |
11,7300 |
Quebec (Qc RMR) |
2,3500 |
Quebec (Other) |
9,3800 |
New-Brunswick |
2,2000 |
Nova Scotia |
2,7200 |
Prince Edward Island |
0,4100 |
Newfoundland |
1,5400 |
Total |
100% |
Label |
Weight |
---|---|
Yes |
27,67000 |
No |
72,33000 |
Total |
100% |
Label |
Weight |
---|---|
French ROC |
2,7100 |
French QC |
18,0900 |
Not French ROC |
73,8300 |
Not French QC |
5,3700 |
Total |
100% |
Label |
Weight |
---|---|
Not University |
72,3300 |
University ROC |
21,81 |
University QC |
5,86 |
Total |
100% |
Wave 12:
The tables below present the geographic distribution of respondents, their gender, age, language, level of education and presence of children in the household.
Label |
Unweighted |
Weighted |
---|---|---|
Region |
||
British Columbia and Yukon |
155 |
136 |
Alberta and Northwest Territories |
100 |
112 |
Manitoba, Saskatchewan and Nunavut |
145 |
65 |
Ontario |
300 |
384 |
Quebec |
200 |
235 |
Atlantic |
100 |
69 |
Gender |
||
Men |
480 |
486 |
Women |
510 |
504 |
Age |
||
Between 18 and 34 |
274 |
273 |
Between 35 and 54 |
361 |
341 |
55 years old and over |
365 |
386 |
Language |
||
English |
690 |
687 |
French |
199 |
208 |
Other |
107 |
102 |
Level of education |
||
High school or less |
211 |
280 |
College |
319 |
436 |
University |
465 |
277 |
Presence of children in the household |
||
Yes |
230 |
265 |
No |
764 |
723 |
Weighting factors for wave 12
For the twelfth wave, results were weighted by region, gender, age, language, level of education, and presence of children in the household.
Label |
Weight |
---|---|
British Columbia and Male and Between 18 and 24 |
0,7200 |
British Columbia and Male and Between 25 and 34 |
1,0900 |
British Columbia and Male and Between 35 and 44 |
1,0200 |
British Columbia and Male and Between 45 and 54 |
1,1700 |
British Columbia and Male and Between 55 and 64 |
1,1700 |
British Columbia and Male and 65 + |
1,4100 |
British Columbia and Female and Between 18 and 24 |
0,6800 |
British Columbia and Female and Between 25 and 34 |
1,1100 |
British Columbia and Female and Between 35 and 44 |
1,0800 |
British Columbia and Female and Between 45 and 54 |
1,2500 |
British Columbia and Female and Between 55 and 64 |
1,2500 |
British Columbia and Female and 65 + |
1,6200 |
Alberta and Male and Between 18 and 24 |
0,6500 |
Alberta and Male and Between 25 and 34 |
1,1600 |
Alberta and Male and Between 35 and 44 |
1,0600 |
Alberta and Male and Between 45 and 54 |
0,9900 |
Alberta and Male and Between 55 and 64 |
0,9000 |
Alberta and Male and 65 + |
0,8300 |
Alberta and Female and Between 18 and 24 |
0,6200 |
Alberta and Female and Between 25 and 34 |
1,1400 |
Alberta and Female and Between 35 and 44 |
1,0400 |
Alberta and Female and Between 45 and 54 |
0,9800 |
Alberta and Female and Between 55 and 64 |
0,8900 |
Alberta and Female and 65 + |
0,9600 |
Manitoba/Saskatchewan and Male and Between 18 and 24 |
0,4000 |
Manitoba/Saskatchewan and Male and Between 25 and 34 |
0,5800 |
Manitoba/Saskatchewan and Male and Between 35 and 44 |
0,5300 |
Manitoba/Saskatchewan and Male and Between 45 and 54 |
0,5500 |
Manitoba/Saskatchewan and Male and Between 55 and 64 |
0,5500 |
Manitoba/Saskatchewan and Male and 65+ |
0,5900 |
Manitoba/Saskatchewan and Female and Between 18 and 24 |
0,3800 |
Manitoba/Saskatchewan and Female and Between 25 and 34 |
0,5800 |
Manitoba/Saskatchewan and Female and Between 35 and 44 |
0,5300 |
Manitoba/Saskatchewan and Female and Between 45 and 54 |
0,5500 |
Manitoba/Saskatchewan and Female and Between 55 and 64 |
0,5600 |
Manitoba/Saskatchewan and Female and 65+ |
0,7200 |
Ontario and Male and Between 18 and 24 |
2,2300 |
Ontario and Male and Between 25 and 34 |
3,0600 |
Ontario and Male and Between 35 and 44 |
2,9200 |
Ontario and Male and Between 45 and 54 |
3,4600 |
Ontario and Male and Between 55 and 64 |
3,1600 |
Ontario and Male and 65+ |
3,6300 |
Ontario and Female and Between 18 and 24 |
2,1200 |
Ontario and Female and Between 25 and 34 |
3,1500 |
Ontario and Female and Between 35 and 44 |
3,1900 |
Ontario and Female and Between 45 and 54 |
3,6500 |
Ontario and Female and Between 55 and 64 |
3,3800 |
Ontario and Female and 65+ |
4,4100 |
Quebec and Male and Between 18 and 24 |
1,2100 |
Quebec and Male and Between 25 and 34 |
1,8000 |
Quebec and Male and Between 35 and 44 |
1,8900 |
Quebec and Male and Between 45 and 54 |
2,0300 |
Quebec and Male and Between 55 and 64 |
2,1100 |
Quebec and Male and 65+ |
2,3900 |
Quebec and Female and Between 18 and 24 |
1,1800 |
Quebec and Female and Between 25 and 34 |
1,8100 |
Quebec and Female and Between 35 and 44 |
1,8900 |
Quebec and Female and Between 45 and 54 |
2,0300 |
Quebec and Female and Between 55 and 64 & Quebec and Female and 65+ |
5,1200 |
ATL and Male and Between 18 and 24 |
0,3400 |
ATL and Male and Between 25 and 34 |
0,4600 |
ATL and Male and Between 35 and 44 |
0,4900 |
ATL and Male and Between 45 and 54 |
0,6100 |
ATL and Male and Between 55 and 64 |
0,6500 |
ATL and Male and 65+ |
0,7600 |
ATL and Female and Between 18 and 24 |
0,3300 |
ATL and Female and Between 25 and 34 |
0,4700 |
ATL and Female and Between 35 and 44 |
0,5300 |
ATL and Female and Between 45 and 54 |
0,6500 |
ATL and Female and Between 55 and 64 |
0,6900 |
ATL and Female and 65+ |
0,8900 |
Total |
100% |
Label |
Weight |
---|---|
Yes |
27,67000 |
No |
72,33000 |
Total |
100% |
Label |
Weight |
---|---|
French ROC |
2,7100 |
French QC |
18,0900 |
Not French ROC |
73,8300 |
Not French QC |
5,3700 |
Total |
100% |
Table 38. Weight by Education Level
Label |
Weight |
Not University |
72,3300 |
University ROC |
21,81 |
University QC |
5,86 |
Total |
100% |
Wave 13:
The tables below present the geographic distribution of respondents, their gender, age, language, level of education, presence of children in the household, immigration status and ethnicity.
Label |
Unweighted |
Weighted |
---|---|---|
Region |
||
British Columbia and Yukon |
423 |
409 |
Alberta and Northwest Territories |
305 |
338 |
Manitoba, Saskatchewan and Nunavut |
355 |
196 |
Ontario |
976 |
1,156 |
Quebec |
706 |
707 |
Atlantic |
248 |
207 |
Gender |
||
Men |
1,376 |
1,446 |
Women |
1,630 |
1,550 |
Age |
||
Between 18 and 34 |
804 |
822 |
Between 35 and 54 |
1,137 |
1,027 |
55 years old and over |
1,072 |
1,164 |
Language |
||
English |
2,091 |
2,052 |
French |
677 |
627 |
Other |
236 |
320 |
Level of education |
||
High school or less |
672 |
860 |
College |
946 |
1,285 |
University |
834 |
1,371 |
Children in the household |
||
Yes |
816 |
824 |
No |
2,186 |
2,179 |
Born in Canada |
||
Yes |
2,403 |
2,353 |
No |
610 |
660 |
Ethnicity |
||
Indigenous |
276 |
145 |
Black |
451 |
108 |
Weighting factors for wave 13
For the thirteenth wave, results were weighted by region, gender, age, language and level of education, presence of children in the household and immigration status.
Label |
Weight |
---|---|
British Columbia and Male and Between 18 and 24 |
0,7200 |
British Columbia and Male and Between 25 and 34 |
1,0900 |
British Columbia and Male and Between 35 and 44 |
1,0200 |
British Columbia and Male and Between 45 and 54 |
1,1700 |
British Columbia and Male and Between 55 and 64 |
1,1700 |
British Columbia and Male and 65 + |
1,4100 |
British Columbia and Female and Between 18 and 24 |
0,6800 |
British Columbia and Female and Between 25 and 34 |
1,1100 |
British Columbia and Female and Between 35 and 44 |
1,0800 |
British Columbia and Female and Between 45 and 54 |
1,2500 |
British Columbia and Female and Between 55 and 64 |
1,2500 |
British Columbia and Female and 65 + |
1,6200 |
Alberta and Male and Between 18 and 24 |
0,6500 |
Alberta and Male and Between 25 and 34 |
1,1600 |
Alberta and Male and Between 35 and 44 |
1,0600 |
Alberta and Male and Between 45 and 54 |
0,9900 |
Alberta and Male and Between 55 and 64 |
0,9000 |
Alberta and Male and 65 + |
0,8300 |
Alberta and Female and Between 18 and 24 |
0,6200 |
Alberta and Female and Between 25 and 34 |
1,1400 |
Alberta and Female and Between 35 and 44 |
1,0400 |
Alberta and Female and Between 45 and 54 |
0,9800 |
Alberta and Female and Between 55 and 64 |
0,8900 |
Alberta and Female and 65 + |
0,9600 |
Manitoba/Saskatchewan and Male and Between 18 and 24 |
0,4000 |
Manitoba/Saskatchewan and Male and Between 25 and 34 |
0,5800 |
Manitoba/Saskatchewan and Male and Between 35 and 44 |
0,5300 |
Manitoba/Saskatchewan and Male and Between 45 and 54 |
0,5500 |
Manitoba/Saskatchewan and Male and Between 55 and 64 |
0,5500 |
Manitoba/Saskatchewan and Male and 65+ |
0,5900 |
Manitoba/Saskatchewan and Female and Between 18 and 24 |
0,3800 |
Manitoba/Saskatchewan and Female and Between 25 and 34 |
0,5800 |
Manitoba/Saskatchewan and Female and Between 35 and 44 |
0,5300 |
Manitoba/Saskatchewan and Female and Between 45 and 54 |
0,5500 |
Manitoba/Saskatchewan and Female and Between 55 and 64 |
0,5600 |
Manitoba/Saskatchewan and Female and 65+ |
0,7200 |
Ontario and Male and Between 18 and 24 & Ontario and Male and Between 25 and 34 |
5,2900 |
Ontario and Male and Between 35 and 44 |
2,9200 |
Ontario and Male and Between 45 and 54 |
3,4600 |
Ontario and Male and Between 55 and 64 |
3,1600 |
Ontario and Male and 65+ |
3,6300 |
Ontario and Female and Between 18 and 24 |
2,1200 |
Ontario and Female and Between 25 and 34 |
3,1500 |
Ontario and Female and Between 35 and 44 |
3,1900 |
Ontario and Female and Between 45 and 54 |
3,6500 |
Ontario and Female and Between 55 and 64 |
3,3800 |
Ontario and Female and 65+ |
4,4100 |
Quebec and Male and Between 18 and 24 & Quebec and Male and Between 25 and 34 |
3,0100 |
Quebec and Male and Between 35 and 44 |
1,8900 |
Quebec and Male and Between 45 and 54 |
2,0300 |
Quebec and Male and Between 55 and 64 |
2,1100 |
Quebec and Male and 65+ |
2,3900 |
Quebec and Female and Between 18 and 24 |
1,1800 |
Quebec and Female and Between 25 and 34 |
1,8100 |
Quebec and Female and Between 35 and 44 |
1,8900 |
Quebec and Female and Between 45 and 54 |
2,0300 |
Quebec and Female and Between 55 and 64 & Quebec and Female and 65+ |
5,1200 |
ATL and Male and Between 18 and 24 & ATL and Male and Between 25 and 34 |
0,8000 |
ATL and Male and Between 35 and 44 |
0,4900 |
ATL and Male and Between 45 and 54 |
0,6100 |
ATL and Male and Between 55 and 64 |
0,6500 |
ATL and Male and 65+ |
0,7600 |
ATL and Female and Between 18 and 24 |
0,3300 |
ATL and Female and Between 25 and 34 |
0,4700 |
ATL and Female and Between 35 and 44 |
0,5300 |
ATL and Female and Between 45 and 54 |
0,6500 |
ATL and Female and Between 55 and 64 |
0,6900 |
ATL and Female and 65+ |
0,8900 |
Total |
100% |
Label |
Weight |
---|---|
Yes |
27,67000 |
No |
72,33000 |
Total |
100% |
Label |
Weight |
---|---|
French ROC |
2,7100 |
French QC |
18,0900 |
Not French ROC |
73,8300 |
Not French QC |
5,3700 |
Total |
100% |
Label |
Weight |
---|---|
Not University |
72,3300 |
University ROC |
21,81 |
University QC |
5,86 |
Total |
100% |
Label |
Weight |
---|---|
Yes |
78,1000 |
No |
21,9000 |
Total |
100% |
Label |
Weight |
---|---|
Indigenous |
4,8100 |
Black |
3,45 |
Other |
91,74 |
Total |
100% |
Wave 14:
The tables below present the geographic distribution of respondents, their gender, age, language, level of education, presence of children in the household, status of immigration and ethnicity.
Label |
Unweighted |
Weighted |
---|---|---|
Region |
||
British Columbia and Yukon |
405 |
408 |
Alberta and Northwest Territories |
320 |
338 |
Manitoba, Saskatchewan and Nunavut |
368 |
196 |
Ontario |
960 |
1,154 |
Quebec |
703 |
706 |
Atlantic |
253 |
207 |
Gender |
||
Men |
1,424 |
1,448 |
Women |
1,566 |
1,548 |
Age |
||
Between 18 and 34 |
875 |
821 |
Between 35 and 54 |
1,019 |
1,026 |
55 years old and over |
1,115 |
1,163 |
Language |
||
English |
2,058 |
2,037 |
French |
669 |
626 |
Other |
263 |
324 |
Level of education |
||
High school or less |
688 |
924 |
College |
914 |
1,239 |
University |
1,396 |
833 |
Children in the household |
||
Yes |
782 |
823 |
No |
2,220 |
2,176 |
Born in Canada |
||
Yes |
2,356 |
2,350 |
No |
653 |
659 |
Ethnicity |
||
Indigenous |
278 |
145 |
Black |
447 |
110 |
Weighting factors for wave 14
For the fourteenth wave, final results were weighted by region, age, gender, language, education levels, presence of children in the household, immigration status, and ethnicity.
Label |
Weight |
---|---|
British Columbia and Male and Between 18 and 24 |
0,7200 |
British Columbia and Male and Between 25 and 34 |
1,0900 |
British Columbia and Male and Between 35 and 44 |
1,0200 |
British Columbia and Male and Between 45 and 54 |
1,1700 |
British Columbia and Male and Between 55 and 64 |
1,1700 |
British Columbia and Male and 65 + |
1,4100 |
British Columbia and Female and Between 18 and 24 |
0,6800 |
British Columbia and Female and Between 25 and 34 |
1,1100 |
British Columbia and Female and Between 35 and 44 |
1,0800 |
British Columbia and Female and Between 45 and 54 |
1,2500 |
British Columbia and Female and Between 55 and 64 |
1,2500 |
British Columbia and Female and 65 + |
1,6200 |
Alberta and Male and Between 18 and 24 |
0,6500 |
Alberta and Male and Between 25 and 34 |
1,1600 |
Alberta and Male and Between 35 and 44 |
1,0600 |
Alberta and Male and Between 45 and 54 |
0,9900 |
Alberta and Male and Between 55 and 64 |
0,9000 |
Alberta and Male and 65 + |
0,8300 |
Alberta and Female and Between 18 and 24 |
0,6200 |
Alberta and Female and Between 25 and 34 |
1,1400 |
Alberta and Female and Between 35 and 44 |
1,0400 |
Alberta and Female and Between 45 and 54 |
0,9800 |
Alberta and Female and Between 55 and 64 |
0,8900 |
Alberta and Female and 65 + |
0,9600 |
Manitoba/Saskatchewan and Male and Between 18 and 24 & Manitoba/Saskatchewan and Male and Between 25 and 34 |
0,9800 |
Manitoba/Saskatchewan and Male and Between 35 and 44 |
0,5300 |
Manitoba/Saskatchewan and Male and Between 45 and 54 |
0,5500 |
Manitoba/Saskatchewan and Male and Between 55 and 64 |
0,5500 |
Manitoba/Saskatchewan and Male and 65+ |
0,5900 |
Manitoba/Saskatchewan and Female and Between 18 and 24 |
0,3800 |
Manitoba/Saskatchewan and Female and Between 25 and 34 |
0,5800 |
Manitoba/Saskatchewan and Female and Between 35 and 44 |
0,5300 |
Manitoba/Saskatchewan and Female and Between 45 and 54 |
0,5500 |
Manitoba/Saskatchewan and Female and Between 55 and 64 |
0,5600 |
Manitoba/Saskatchewan and Female and 65+ |
0,7200 |
Ontario and Male and Between 18 and 24 |
2,2300 |
Ontario and Male and Between 25 and 34 |
3,0600 |
Ontario and Male and Between 35 and 44 |
2,9200 |
Ontario and Male and Between 45 and 54 |
3,4600 |
Ontario and Male and Between 55 and 64 |
3,1600 |
Ontario and Male and 65+ |
3,6300 |
Ontario and Female and Between 18 and 24 |
2,1200 |
Ontario and Female and Between 25 and 34 |
3,1500 |
Ontario and Female and Between 35 and 44 |
3,1900 |
Ontario and Female and Between 45 and 54 |
3,6500 |
Ontario and Female and Between 55 and 64 |
3,3800 |
Ontario and Female and 65+ |
4,4100 |
Quebec and Male and Between 18 and 24 |
1,2100 |
Quebec and Male and Between 25 and 34 |
1,8000 |
Quebec and Male and Between 35 and 44 |
1,8900 |
Quebec and Male and Between 45 and 54 |
2,0300 |
Quebec and Male and Between 55 and 64 |
2,1100 |
Quebec and Male and 65+ |
2,3900 |
Quebec and Female and Between 18 and 24 |
1,1800 |
Quebec and Female and Between 25 and 34 |
1,8100 |
Quebec and Female and Between 35 and 44 |
1,8900 |
Quebec and Female and Between 45 and 54 |
2,0300 |
Quebec and Female and Between 55 and 64 & Quebec and Female and 65+ |
5,1200 |
ATL and Male and Between 18 and 24 |
0,3400 |
ATL and Male and Between 25 and 34 |
0,4600 |
ATL and Male and Between 35 and 44 |
0,4900 |
ATL and Male and Between 45 and 54 |
0,6100 |
ATL and Male and Between 55 and 64 |
0,6500 |
ATL and Male and 65+ |
0,7600 |
ATL and Female and Between 18 and 24 |
0,3300 |
ATL and Female and Between 25 and 34 |
0,4700 |
ATL and Female and Between 35 and 44 |
0,5300 |
ATL and Female and Between 45 and 54 |
0,6500 |
ATL and Female and Between 55 and 64 |
0,6900 |
ATL and Female and 65+ |
0,8900 |
Total |
100% |
Label |
Weight |
---|---|
British Columbia (Vancouver RMR) |
7,2000 |
British Columbia (Other) |
6,3700 |
Alberta (Calgary RMR) |
3,8400 |
Alberta (Edmonton RMR) |
3,6500 |
Alberta (Other) |
3,7300 |
Saskatchewan |
3,0100 |
Manitoba |
3,5100 |
Ontario (Tor RMR) |
16,9200 |
Ontario (Other) |
21,4400 |
Quebec (Mtl RMR) |
11,7300 |
Quebec (Qc RMR) |
2,3500 |
Quebec (Other) |
9,3800 |
New-Brunswick |
2,2000 |
Nova Scotia |
2,7200 |
Prince Edward Island |
0,4100 |
Newfoundland |
1,5400 |
Total |
100% |
Label |
Weight |
---|---|
Not University |
72,3300 |
University |
21,81 |
University QC |
5,86 |
Total |
100% |
Label |
Weight |
---|---|
Yes, children |
27,67 |
No |
72,33 |
Total |
100% |
Label |
Weight |
---|---|
Born in Canada |
78,1000 |
Born outside Canada |
21,9000 |
Total |
100% |
Label |
Weight |
---|---|
Indigenous |
4,8100 |
Black |
3,45 |
Other |
91,74 |
Total |
100% |
Leger conducted a series of eight focus group sessions with French-speaking and English-speaking Canadians. Conducting the groups online offered the opportunity to regroup people from all the regions in Canada. Three focus groups were held with young adults aged 18-34 years old, three other focus groups were held with adults aged 35-60 years old, and two focus groups were held with parents. The first two demographics were interviewed using the same discussion guide, while the parent groups discussion guide focused on specific aspects relating to children vaccination and health. Overall, three focus groups were conducted in French (one of each demographic), and the remaining five in English. For each online focus group, ten participants were recruited by our professional recruiters. In the end, a total of 64 participants took part in the online focus groups (see table 53 for details). All participants in the focus groups received an honorarium of $135.
The focus groups were conducted online using Focus Vision's CMNTY platform. This platform allowed for video conferencing groups, observers in a separate virtual room, chat between participants and the moderator, and chat between the observation room and the moderator. Each group was 120 minutes long, to ensure the participation of each participant. All sessions allowed for remote viewing by Leger and Government of Canada observers. All groups were scheduled to be held on June 20, 21 or 22, 2022. However, due to technical difficulties, two groups had to be rescheduled in the last week of June and one in July.
GR |
Region |
Recruits |
Participants |
Target |
Time |
Language |
Date |
---|---|---|---|---|---|---|---|
1 |
Ontario |
10 |
8 |
Young adults (18-34) |
5pm |
English |
June 20th, 2022 |
2 |
BC, Prairies, Territories |
10 |
9 |
Young adults (18-34) |
5pm |
English |
July 6th, 2022 (originally scheduled on June 20th, 2022) |
3 |
Québec, New-Brunswick |
10 |
10 |
Young adults (18-34) |
5pm |
French |
June 20th, 2022 |
4 |
BC, Prairies, Territories |
10 |
8 |
Adults (35-60) |
5pm |
English |
June 21st, 2022 |
5 |
Ontario |
10 |
9 |
Adults (35-60) |
7pm |
English |
June 21st, 2022 |
6 |
Québec, New-Brunswick |
10 |
8 |
Adults (35-60) |
5pm |
French |
June 29th, 2022 (originally scheduled on June 20th, 2022) |
7 |
BC, Prairies, Ontario |
10 |
3 |
Parents |
5pm |
English |
June 22nd, 2022 |
8 |
Québec, New-Brunswick |
10 |
9 |
Parents |
5pm |
French |
June 21st, 2022 |
Total |
80 |
64 |
Recruitment was carried out by professional recruiters. The recruitment guide (available in the appendix F) ensured that the participants met the profiles sought for each session and that they were equipped to participate in an online discussion session. To do so, they had to confirm that they had a high-speed Internet connexion, a computer or laptop. Group #7 had a low participation rate. Only 5 participants showed up on time for the group. Since the moderator did not receive any messages from clients or observers, it was decided to move forward with the group to avoid having to reschedule another group. Group #7 started with five participants, but two dropped out due to technical difficulties.
All focus group sessions were moderated and supervised by a Leger researcher assisted by a research analyst. Two researchers moderated the groups in French and two others moderated the groups in English. The discussion guides (available in appendixes G and H) consisted of a semi-structured discussion guide. It allowed moderators to follow the thread of the discussion and ensured that an array of themes was covered while leaving sufficient room for the participants to express themselves and develop in detail their experiences, ideas, opinions and perceptions.
This qualitative portion of the research provides insight into the opinions of a population, rather than providing a measure in percent of the opinions held, as would be measured in a quantitative study. The results of this type of research should be viewed as directional only. No inference to the general population can be done with the results of this research.
Leger recruited participants with the help of CRC Research, our qualitative recruitment partner, using a hybrid method. First, an online screening was used followed by a final recruitment screening over the phone. The online recruitment enabled us to find many potential candidates that fit the recruitment criteria across all regions of Canada. Then, these potential candidates were contacted by phone by CRC's professional recruiters to confirm their eligibility and that they have access to a computer, a high-speed online connection as well as a webcam to participate in the online discussion session. After being adequately screened and recruited, participants (as well as observers) received detailed instructions from CRC Research on how to log in to the live session and other key information regarding the procedure itself.
The recruitment screener informed participants of all their rights under Canada's Privacy legislation and the Standards for the Conduct of Government of Canada Public Opinion Research. Specifically, their confidentiality was guaranteed, and that participation is voluntary.
After each group, a meeting was organized with the researchers in order to get the general outlines and trends.
Thank you for agreeing to take part in this survey. We anticipate that the survey will take approximately 12 minutes to complete.
Background information
This research is being conducted by Léger Marketing, a Canadian public opinion research firm on behalf of Health Canada.
The purpose of this online survey is to collect opinions and feedback from Canadians that will be used by Health Canada to help inform government actions and decisions.
How does the online survey work? You are being asked to offer your opinions and experiences through an online survey. You have to be 18 or over in order to participate in this survey. We anticipate that the survey will take 12 minutes to complete. Your participation in the survey is completely voluntary. Your responses are confidential and will only ever be reported in aggregate – never in any way that can identify any individual respondent or their responses. Your decision on whether or not to participate will not affect any dealings you may have with the Government of Canada.
What about your personal information? The personal information you provide to Health Canada is governed in accordance with the Privacy Act and is being collected under the authority of section 4 of the Department of Health Act in accordance with the Treasury Board Directive on Privacy Practices. We only collect the information we need to conduct the research project. Purpose of collection: We require your personal information such as demographic information to better understand the topic of the research. However, your responses are always combined with the responses of others for analysis and reporting; you will never be identified. Your rights under the Privacy Act: In addition to protecting your personal information, the Privacy Act gives you the right to request access to and correction of your personal information. For more information about these rights, or about our privacy practices, please contact Health Canada's Privacy Coordinator at 613-948-1219 or privacy-vie.privee@hc-sc.gc.ca. You also have the right to file a complaint with the Privacy Commissioner of Canada if you think your personal information has been handled improperly.
If you are experiencing technical issues while responding to the survey, please contact Leger's technical support team at support@legeropinion.com.
Your help is greatly appreciated, and we look forward to receiving your feedback.
[GDR] What is your gender identity?
Gender refers to current gender which may be different from sex assigned at birth and may be different from what is indicated on legal documents.
Row:
[PROV] In which province or territory do you currently live?
Row:
[YEAR] In what year and month were you born?
[AGE2] Would you be willing to indicate in which of the following age categories you belong?
Condition: (AGERef.r1)
Row:
[ETHNIC] Do you identify as any of the following?
Select all that apply
Row:
[CHILD] Are you the parent or guardian of a child or children under 18 years of age living in your household?
Row:
[CHILD_AGE] How old is/are the child/children?
Condition: (CHILD.r1)
Select all that apply
Row:
[CHILDB] How many children do you have in each of the following age categories?
Condition: (CHILD.r1)
Row:
[Q1] What is currently your most pressing concern, if any, related to COVID-19?
Row:
[Q3] How would you rate your mental health now compared to before the pandemic?
Row:
[Q72] Please indicate if the situations listed below changed for you since the beginning of the pandemic by selecting increased, decreased or the same/no change.
Column:
Row:
[Q73] What is your primary source of information when seeking credible information on mental health?
Please select only one.
Row:
[Q74] Have you ever heard of or visited the Wellness Together Canada portal, which offers free and confidential mental health and substances use support such as one on one counselling services?
Row:
[Q75] What kind of information would you like to find on a Government of Canada mental health website?
Please select up to 3 choices.
Row:
[Q4] Since the start of the pandemic, have you received any support for coping with mental health during COVID-19?
Row:
[Q5] How worried are you, if at all, when thinking about life after the pandemic ends?
Row:
[Q6] What makes you feel worried?
Condition: (Q5.r1 or Q5.r2)
Select all that apply
Row:
[Q7] When you think about what your day-to-day life will look like post-pandemic, do you think it will look more like pre-pandemic times or more like it did during the pandemic?
Row:
[Q8] To what extent are you paying attention to messages from public health authorities on COVID-19?
Row:
[Q10] Have you received a COVID-19 vaccine (at least one dose)?
Row:
[Q11] How many doses have you received?
Condition: (Q10.r1)
Row:
[Q17] What is the main reason you have not received a COVID-19 vaccine?
Condition: (Q10.r2)
Row:
[Q18] What is the main reason why you would eventually get a vaccination, but would wait a while first?
Condition: (Q17.r5)
Row:
[Q19] What is the main reason why you will not get vaccinated?
Condition: (Q17.r6)
Row:
[Q76] Amongst the following factors and thinking about the current COVID context, what would motivate you to get vaccinated?
Condition: (Q10.r2)
Please select up to your top 3
Row:
[Q22] As we learn more about real world effectiveness of the COVID-19 vaccines, if a third vaccine dose or "booster" is needed in order to provide protection in the long-term or to protect against new variant strains, would you be willing to get another dose?
Condition: (Q11.r1 or Q11.r2)
Row:
[Q23] What is the top reason you would not get or are uncertain about getting a third dose or booster dose?
Condition: (Q22.r3 or Q22.r4)
Row:
[Q77] If a booster of COVID-19 vaccine is recommended to provide protection in the long-term or to protect against new variant strains; would you accept a vaccine that is a different brand from the COVID-19 vaccine products that you previously received?
Condition: (Q22.r1 or Q22.r2)
Row:
[Q78A] If a booster of COVID-19 vaccine is recommended to provide protection in the long-term or to protect against new variant strains, would you have a product preference?
Condition: (Q22.r1 or Q22.r2)
Row:
[Q78B] Which one?
Condition: (Q78A.r1)
Row:
[Q79] Thinking about booster vaccines, which of the following statements best represents you?
Row:
[Q80] Thinking about your child aged 12-17, have they received at least one dose of a COVID-19 vaccine?
Condition: (CHILDB.r3.check('=1'))
Row:
[Q80B] Thinking about your children aged 12-17, have they received at least one dose of a COVID-19 vaccine?
Condition: (CHILDB.r3.check('>1'))
Row:
[Q81] How many doses have your vaccinated children aged 12-17 received?
Condition: (Q80.r1)
Row:
[Q81B] How many doses have your vaccinated children received?
Condition: (Q80B.r1 or Q80B.r2)
Row:
[Q82] Thinking about your child/children aged 5-11, if a COVID-19 vaccine becomes available to your child/children, would you choose to get your child/children vaccinated?
Condition: (CHILD_AGE.r2)
Row:
[Q83] What is the main reason why you would eventually choose for your child/children to get vaccinated, but would wait a while first?
Condition: (Q80.r2) or (Q82.r2) or (Q80B.r3)
Row:
[Q27] What are the main reasons for not choosing to have the child(ren) under your care or guardianship vaccinated with a COVID-19 vaccine or for being not sure?
Condition: (Q82.r3 or Q82.r98) or (Q80.r3 or Q80.r98) or (Q80B.r4 or Q80B.r98)
Select up to 3 reasons.
Row:
[Q84] Thinking about COVID-19 vaccine for your child/children under 12, which of the following statements best represents what you want?
Condition: (CHILDB.r1.check('>0') or CHILDB.r2.check('>0'))
Row:
[Q85] If COVID-19 vaccine products become authorized for use in children under 12, which vaccine products would you prefer your child/children to receive?
Condition: (CHILDB.r1.check('>0') or CHILDB.r2.check('>0'))
Row:
[Q28] Which of the following factors would make you more likely to vaccinate your child(ren) against COVID-19?
Condition: (Q80.r2 or Q80.r3) or (Q80B.r3 or Q80B.r4) or (CHILDB.r1.check('>0') or CHILDB.r2.check('>0'))
Choose your top three.
Row:
[Q29] Outside of the COVID-19 pandemic, please indicate the extent to which you agree with the following statement. "I think it is important for everyone to get the recommended vaccines for their children."
Condition: (CHILD.r1)
Row:
[Q86] To what extent would you support or oppose the following? Requiring that employees must be vaccinated against COVID-19 and provide proof of vaccination to their employer in order to continue working in-person/on site for their employer.
Row:
[Q87] Why do you somewhat or strongly oppose proof of vaccination in the workplace?
Condition: (Q86.r4 or Q86.r5)
Please select all that apply
Row:
[grid3] Even if public health measures are eased or lifted in your area, how likely are you to continue to do the following?
Column:
Row:
[grid4] If some public health measures had to be reintroduced to prevent a widespread outbreak or resurgence, how likely would you be to follow them?
Column:
Row:
[grid5] In post-pandemic times, how likely would you be to follow public health measures such as mask wearing and practicing physical distancing in each of the following scenarios?
Column:
Row:
[Q55] Some businesses are implementing workplace screening programs using COVID-19 rapid tests. Employees are tested using a short nasal swab twice per week before entering their workplace to make sure they aren't infected with the virus. If your workplace decided to implement a COVID-19 rapid test screening program, would you participate in it?
Row:
[Q56] What is the main reason you would not want to participate in a workplace screening program using rapid tests?
Condition: (Q55.r3)
Row:
[Q57] If you had symptoms of a viral infection, would you use rapid tests from a COVID-19 assessment centre, care clinic, or community testing site or a self-administered test to help distinguish a COVID-19 diagnosis from the flu or common cold?
Row:
[Q88] If you were required to cover a $10-$40 cost for each rapid test, would you still be willing to undergo testing?
Condition: (Q57.r1)
Row:
[Q59] Do you plan to get your flu shot this year?
Row:
[Q60] Why are you not planning on getting your flu shot this year?
Condition: (Q59.r2)
(select all that apply)
Row:
[Q61] Please indicate the extent to which you agree with the following statement. "A COVID-19 vaccine booster dose in the fall/winter would make me less likely to get the flu shot."
Row:
[Q62] How much do you feel you are at higher or lower risk of flu-related complications if you do get the flu?
Row:
[Q69] Do you plan to get your child/children vaccinated against the flu this year?
Condition: (CHILD.r1)
Row:
[Q70] What are the main reasons for not choosing to have the child(ren) under your care or guardianship vaccinated against the flu or for being not sure?
Condition: (Q69.r2 or Q69.r98)
Select up to 3 reasons.
Row:
The last few questions are strictly for statistical purposes. All of your answers are completely confidential.
[LANGU] What is the language you first learned at home as a child and still understand?
Row:
[MINO] Do you identify as any of the following?
SELECT ALL THAT APPLY
Row:
[IMM] Where were you born?
Row:
[YIMM] In what year did you move to Canada?
Condition: (IMM.r2)
[MainAutoCountry] What is your country of origin?
Condition: (IMM.r2)
[PAYS] What is your country of origin?
Condition: (IMM.r2)
[PREGNANT] Are you pregnant or do you intend to become pregnant within the next year?
Condition: (GDR.r2)
Row:
[HEALTHCONDITION] Are you currently living with one or more of the following health conditions?
(select all that apply)
Row:
[SCOL] What is the highest level of formal education that you have completed?
SELECT ONE ONLY
Row:
[OCCUP] Which of the following categories best describes your current employment status? Are you...
SELECT ONE ONLY
Row:
[OCCUP2] Are you a healthcare provider (such as nurse, medical doctor, paramedic, first responder, pharmacist, etc.) and/or a frontline worker or essential worker (such as gas station attendant, bus driver, grocery store clerk, media workers, laboratory workers, etc.)?
Condition: (OCCUP.r1 or OCCUP.r2)
Row:
[REVEN] Which of the following categories best describes your total household income? That is, the total income of all persons in your household combined, before taxes?
SELECT ONE ONLY
Row:
[FSA] Please indicate the first 3 characters of your postal code.
If you would rather not provide it, please select I don't know/I prefer not to answer
Thank you for agreeing to take part in this survey. We anticipate that the survey will take approximately 12 minutes to complete.
Background information
This research is being conducted by Léger Marketing, a Canadian public opinion research firm on behalf of Health Canada.
The purpose of this online survey is to collect opinions and feedback from Canadians that will be used by Health Canada to help inform government actions and decisions.
How does the online survey work? You are being asked to offer your opinions and experiences through an online survey. You have to be 18 or over in order to participate in this survey. We anticipate that the survey will take 12 minutes to complete. Your participation in the survey is completely voluntary. Your responses are confidential and will only ever be reported in aggregate – never in any way that can identify any individual respondent or their responses. Your decision on whether or not to participate will not affect any dealings you may have with the Government of Canada. What about your personal information? The personal information you provide to Health Canada is governed in accordance with the Privacy Act and is being collected under the authority of section 4 of the Department of Health Act in accordance with the Treasury Board Directive on Privacy Practices. We only collect the information we need to conduct the research project. Purpose of collection: We require your personal information such as demographic information to better understand the topic of the research. However, your responses are always combined with the responses of others for analysis and reporting; you will never be identified. Your rights under the Privacy Act: In addition to protecting your personal information, the Privacy Act gives you the right to request access to and correction of your personal information. For more information about these rights, or about our privacy practices, please contact Health Canada's Privacy Coordinator at 613-948-1219 or privacy-vie.privee@hc-sc.gc.ca. You also have the right to file a complaint with the Privacy Commissioner of Canada if you think your personal information has been handled improperly.
If you are experiencing technical issues while responding to the survey, please contact Leger's technical support team at support@legeropinion.com.
Your help is greatly appreciated, and we look forward to receiving your feedback.
[GDR] What is your gender identity?
Gender refers to current gender which may be different from sex assigned at birth and may be different from what is indicated on legal documents.
Row:
[PROV] In which province or territory do you currently live?
Row:
[YEAR] In what year and month were you born?
[AGE2] Would you be willing to indicate in which of the following age categories you belong?
Condition: (AGERef.r1)
Row:
[ETHNIC] Do you identify as any of the following?
Select all that apply
Row:
[CHILD] Are you the parent or guardian of a child or children under 18 years of age living in your household?
Row:
[CHILD_AGE] How old is/are the child/children?
Condition: (CHILD.r1)
Select all that apply
Row:
[CHILDB] How many children do you have in each of the following age categories?
Condition: (CHILD.r1)
Row:
[Q89] Are you or have you been infected with COVID-19?
Row:
[Q90] Do you know people in your immediate social network (i.e., friends or close family members) who have been infected with COVID-19?
Row:
[Q1] What is currently your most pressing concern, if any, related to COVID-19?
Row:
[Q3] How would you rate your mental health now compared to before the pandemic?
Row:
[Q3B] How would you rate your mental health now compared to two weeks ago?
Row:
[Q72] Please indicate if the situations listed below changed for you since the beginning of the pandemic by selecting increased, decreased or the same/no change.
Column:
Row:
[Q4] Since the start of the pandemic, have you received any support for coping with mental health?
Row:
[Q4B] What type of support have your received?
Condition: (Q4.r1)
Select all that apply.
Row:
[Q5] How worried are you, if at all, when thinking about life after the pandemic ends?
Row:
[Q6] What makes you feel worried?
Condition: (Q5.r1 or Q5.r2)
Select all that apply
Row:
[Q91] How often do you use the following sources of information to stay informed about COVID-19?
Column:
Row:
[Q10] Have you received a COVID-19 vaccine (at least one dose)?
Row:
[Q11] How many doses have you received?
Condition: (Q10.r1)
Row:
[Q92] How likely are you to get the booster dose of the COVID-19 vaccine?
Condition: (Q11.r1 or Q11.r2)
Row:
[Q93] What is the top reason you are unlikely or uncertain about getting a booster dose?
Condition: (Q92.r3 or Q92.r4 or Q92.r98)
Row:
[Q76] Amongst the following factors and thinking about the current COVID context, what would motivate you to get your booster dose?
Condition: (Q11.r1 or Q11.r2)
Please select up to your top 3
Row:
[Q94] If a booster dose were developed for a specific COVID-19 variant, how likely would you be to get it?
Row:
[Q80] Thinking about your child(ren) aged 12-17, have they received at least one dose of a COVID-19 vaccine?
Condition: (CHILDB.r3.check('> 0'))
Row:
[Q81] How many doses have your vaccinated child(ren) aged 12-17 received?
Condition: (Q80.r1)
Select all that apply
Row:
[Q95] Thinking about your child(ren) aged 12-17, if a booster becomes available for them, how likely would you be to have them receive one?
Condition: (CHILDB.r3.check('>0'))
Row:
[Q96] Thinking about your child(ren) aged 5-11, have they received at least one dose of a COVID-19 vaccine?
Condition: (CHILDB.r2.check('>0'))
Select all that apply
Row:
[Q97] How many doses have your vaccinated child(ren) aged 5-11 received?
Condition: (Q96.r1)
Select all that apply
Row:
[Q98] Thinking about your child(ren) under 5, if a COVID-19 vaccine becomes available to your child/children, would you choose to get your child(ren) under 5 vaccinated?
Condition: (CHILDB.r1.check('>0'))
Row:
[Q28] Which of the following factors would make you more likely to vaccinate your child(ren) against COVID-19?
Condition: (Q80.r2 or Q80.r3 or Q80.r98) or (Q96.r3 or Q96.r2 or Q96.r98) or (CHILDB.r1.check('>0'))
Please choose your top three.
Row:
[Q1B] How often do you follow each of the following public health measures?
Column:
Row:
[Q99] What type of mask do you most often wear?
Condition: (Q1B.r7.c1 or Q1B.r7.c2 or Q1B.r7.c3) or (Q1B.r8.c1 or Q1B.r8.c2 or Q1B.r8.c3)
Row:
[Q100] Why are you not always or often following each of these public health measures?
Condition: Q1B.c3.any or Q1B.c4.any or Q1B.c5.any
Select all that apply.
Row:
[Q101] To what extent do you think following PHMs help to protect yourself and others from COVID-19?
Row:
[Q102] When the COVID-19 pandemic is over, for which reason(s) would you choose to wear a mask?
Select all that apply.
Row:
[Q103] In the past month, have you…
Column:
[c98] Prefer not to answer
Row:
[Q104] Is your workplace running a workplace rapid testing screening program?
Row:
[Q104B] Do you feel that the workplace rapid testing screening program is helping to protect you in the workplace?
Condition: (Q104.r1)
Row:
[Q55] Some businesses are implementing workplace rapid testing screening programs using COVID-19 rapid tests. Employees are tested using a short nasal swab twice per week before entering their workplace to make sure they aren't infected with the virus. If your workplace decided to implement a workplace rapid testing screening program, would you participate in it?
Condition: (Q104.r2)
Row:
[Q56] What is the main reason you would not want to participate in a workplace screening program using rapid tests?
Condition: (Q55.r3)
Row:
[Q105] If you had access to rapid testing for personal use (outside of your workplace), how would you prefer to receive a rapid test?
Row:
[Q88] If you were required to cover a $10-$40 cost for each rapid test, would you still be willing to undergo testing?
Row:
[Q106] If there was an online reporting tool, would you report your results if anonymous?
Row:
The last few questions are strictly for statistical purposes. All of your answers are completely confidential.
[LANGU] What is the language you first learned at home as a child and still understand?
Row:
[MINO] Do you identify as any of the following?
SELECT ALL THAT APPLY
Row:
[IMM] Where were you born?
Row:
[YIMM] In what year did you move to Canada?
Condition: (IMM.r2)
[MainAutoCountry] What is your country of origin?
Condition: (IMM.r2)
[PAYS] What is your country of origin?
Condition: (IMM.r2)
[SCOL] What is the highest level of formal education that you have completed?
SELECT ONE ONLY
Row:
[OCCUP] Which of the following categories best describes your current employment status? Are you...
SELECT ONE ONLY
Row:
[OCCUP2] Are you a healthcare provider (such as nurse, medical doctor, paramedic, first responder, pharmacist, etc.) and/or a frontline worker or essential worker (such as gas station attendant, bus driver, grocery store clerk, media worker, laboratory worker, etc.)?
Condition: (OCCUP.r1 or OCCUP.r2)
Row:
[REVEN] Which of the following categories best describes your total household income? That is, the total income of all persons in your household combined, before taxes?
SELECT ONE ONLY
Row:
[HH_SIZE] How many people, including yourself, are supported by your total household income?
[FSA] Please indicate the first 3 characters of your postal code.
If you would rather not provide it, please select I don't know/I prefer not to answer
Thank you for agreeing to take part in this survey. We anticipate that the survey will take approximately 12 minutes to complete.
Background information
This research is being conducted by Léger Marketing, a Canadian public opinion research firm on behalf of Health Canada.
The purpose of this online survey is to collect opinions and feedback from Canadians that will be used by Health Canada to help inform government actions and decisions.
How does the online survey work? You are being asked to offer your opinions and experiences through an online survey. You have to be 18 or over in order to participate in this survey. We anticipate that the survey will take 12 minutes to complete. Your participation in the survey is completely voluntary. Your responses are confidential and will only ever be reported in aggregate – never in any way that can identify any individual respondent or their responses. Your decision on whether or not to participate will not affect any dealings you may have with the Government of Canada. What about your personal information? The personal information you provide to Health Canada is governed in accordance with the Privacy Act and is being collected under the authority of section 4 of the Department of Health Act in accordance with the Treasury Board Directive on Privacy Practices. We only collect the information we need to conduct the research project. Purpose of collection: We require your personal information such as demographic information to better understand the topic of the research. However, your responses are always combined with the responses of others for analysis and reporting; you will never be identified. Your rights under the Privacy Act: In addition to protecting your personal information, the Privacy Act gives you the right to request access to and correction of your personal information. For more information about these rights, or about our privacy practices, please contact Health Canada's Privacy Coordinator at 613-948-1219 or privacy-vie.privee@hc-sc.gc.ca. You also have the right to file a complaint with the Privacy Commissioner of Canada if you think your personal information has been handled improperly.
If you are experiencing technical issues while responding to the survey, please contact Leger's technical support team at support@legeropinion.com.
Your help is greatly appreciated, and we look forward to receiving your feedback.
[GDR] What is your gender identity?
Gender refers to current gender which may be different from sex assigned at birth and may be different from what is indicated on legal documents.
Row:
[PROV] In which province or territory do you currently live?
Row:
[YEAR] In what year and month were you born?
[AGE2] Would you be willing to indicate in which of the following age categories you belong?
Condition: (AGERef.r1)
Row:
[ETHNIC] Do you identify as any of the following?
Select all that apply
Row:
[CHILD] Are you the parent or guardian of a child or children under 18 years of age living in your household?
Row:
[CHILD_AGE] How old is/are the child/children?
Condition: (CHILD.r1)
Select all that apply
Row:
[Q89] Are you or have you been infected with COVID-19?
Row:
[Q90] Do you know people in your immediate social network (i.e., friends or close family members) who have been infected with COVID-19?
Row:
[Q107] Among those you know who were infected with COVID-19, do you know anyone who has become very ill with COVID-19? This would include anyone who was admitted to hospital or died from COVID-19.
Condition: Q90.r1
Row:
[Q1] What is currently your most pressing concern, if any, related to COVID-19?
Row:
[Q3] How would you rate your mental health now compared to before the pandemic?
Row:
[Q3B] How would you rate your mental health now compared to two weeks ago?
Row:
[Q72] Please indicate if the situations listed below changed for you since the beginning of the pandemic by selecting increased, decreased or the same/no change.
Column:
Row:
[Q108] Please indicate your level of agreement with the following statement: I feel I have adequate access to mental health support services.
Row:
[Q4] In the past month, have you received any support for your mental health?
Row:
[Q4B] What type of support have your received?
Condition: (Q4.r1)
Select all that apply.
Row:
[Q5] How worried are you, if at all, when thinking about life in the next 6 months?
Row:
[Q6] What makes you feel worried?
Condition: (Q5.r1 or Q5.r2)
Select all that apply
Row:
[Q10] Have you received a COVID-19 vaccine (at least one dose)?
Row:
[Q11] How many doses have you received?
Condition: (Q10.r1)
Row:
[Q92] How likely are you to get the booster dose of the COVID-19 vaccine?
Condition: (Q10.r1)
Row:
[Q93] What is the top reason you are unlikely or uncertain about getting a booster dose?
Condition: (Q92.r3 or Q92.r4 or Q92.r98)
Row:
[Q76] Amongst the following factors and thinking about the current COVID context, what would motivate you to get your booster dose?
Condition: Q10.r1 and not(Q92.r5)
Please select up to your top 3
Row:
[Q109] If yearly boosters against COVID-19 were offered, how likely would you be to get one every year?
Row:
[Q80] Thinking about your child(ren) aged 12-17, have they received at least one dose of a COVID-19 vaccine?
Condition: (CHILD_AGE.r3)
Row:
[Q81] How many doses have your vaccinated child(ren) aged 12-17 received?
Condition: (Q80.r1)
Select all that apply
Row:
[Q95] Thinking about your child(ren) aged 12-17, if a booster becomes available for them, how likely would you be to have them receive one?
Condition: (CHILD_AGE.r3)
Row:
[Q110] Why are you not likely or not sure to have your child(ren) aged 12-17 get a booster dose of a COVID-19 vaccine?
Condition: (Q95.r3 or Q95.r4 or Q95.r98)
Select up to 3 reasons.
Row:
[Q96] Thinking about your child(ren) aged 5-11, have they received at least one dose of a COVID-19 vaccine?
Condition: (CHILD_AGE.r2)
Select all that apply
Row:
[Q97] How many doses have your vaccinated child(ren) aged 5-11 received?
Condition: (Q96.r1)
Select all that apply
Row:
[Q98] Thinking about your child(ren) under 5, if a COVID-19 vaccine becomes available to your child/children, would you choose to get your child(ren) under 5 vaccinated?
Condition: (CHILD_AGE.r1)
Row:
[Q28] Which of the following factors would make you more likely to vaccinate your child(ren) against COVID-19?
Condition: (Q80.r2 or Q80.r3 or Q80.r98) or (Q96.r3 or Q96.r2 or Q96.r98) or (CHILD_AGE.r1)
Please choose your top three.
Row:
[Q111] Have any of your child's regular childhood vaccinations been missed/delayed as a result of the pandemic?
Row:
[Q112] Do you intend to catch up on your child's missed/delayed regular childhood vaccinations?
Condition: (Q111.r1)
Row:
[Q113] Has the COVID-19 pandemic affected your intentions for your children to receive their regular recommended childhood vaccinations?
Row:
[Q114] What impact, if any, has the recent COVID-19 pandemic had on your level of concern regarding regular recommended childhood vaccinations?
Row:
[Q1B] How often do you follow each of the following public health measures?
Note: In any questions below that refer to masks, the word mask refers to a non-medical mask, medical mask or respirator (eg: N95 or KN95).
Column:
Row:
[Q115] Many individual public health measures (e.g., staying home when sick, handwashing, mask-wearing, physical distancing) were recommended in 2020 to help control the spread of COVID-19. How much do you think these individual public health measures could help reduce the spread of other respiratory infectious diseases, such as seasonal influenza (the flu)?
Row:
[Q116] Even if public health restrictions are eased or lifted in your area, how likely are you to continue to do the following?
Note: In any questions below that refer to masks, the word mask refers to a non-medical mask, medical mask or respirator (eg: N95 or KN95).
Column:
Row:
[Q102] Thinking about a time when COVID-19 is no longer a pandemic, for which reason(s) would you choose to wear a mask?
Select all that apply.
Row:
[Q103] In the past month, have you…
Column:
Row:
[Q117] Have you ever heard of or used ArriveCAN, which must be used to provide mandatory travel information before and after your entry into Canada?
Row:
[Q103B] In the past month, have you…
Column:
Row:
[Q118] Did you use ArriveCAN to submit your information ahead of your return to Canada?
Condition: Q103B.r3.c1
Row:
[Q119] What were the reasons for not using ArriveCAN ahead of your return to Canada?
Condition: Q118.r2
Please select all that apply.
Row:
[Q120] Are you planning to travel outside of Canada in the next 4 months?
Row:
[Q121] Were you aware you might be randomly selected to be tested for COVID-19 upon arrival?
Condition: (Q103B.r3.c1 or Q120.r1)
Row:
[Q122] If you were randomly selected to be tested for COVID-19 when returning from travel from another country and you were required to submit your results to a pharmacy within three days after arrival in Canada, how likely would you take and submit your results as required?
Condition: (Q103B.r3.c1 or Q120.r1)
Row:
[Q123] Of the following reasons listed below, which best captures why you would not be likely to follow-through with taking an arrival PCR test if randomly chosen?
Condition: (Q122.r3 or Q122.r4)
Please select all that apply.
Row:
[Q124] Of the following reasons listed below, which best captures why you would be likely to follow-through with taking an arrival PCR test if randomly chosen?
Condition: (Q122.r1 or Q122.r2)
Please select all that apply.
Row:
[Q125] If given the choice, knowing that you must complete your test, where would you prefer to be tested?
Condition: (Q103B.r3.c1 or Q120.r1)
Row:
[Q126] Where do you look for information about travel requirements?
Condition: (Q103B.r3.c1 or Q120.r1)
Please select all that apply.
Row:
[Q127] In the last month, have you…
Column:
Row:
[Q128] Why have you used a COVID-19 rapid test?
Condition: (Q127.r1.c1)
Please select all that apply.
Row:
[Q129] Why did you consider using a COVID-19 rapid test, but ultimately decided not to do so?
Condition: (Q127.r3.c1)
Please select all that apply.
Row:
The last few questions are strictly for statistical purposes. All of your answers are completely confidential.
[LANGU] What is the language you first learned at home as a child and still understand?
Row:
[MINO] Do you identify as any of the following?
SELECT ALL THAT APPLY
Row:
[IMM] Where were you born?
Row:
[YIMM] In what year did you move to Canada?
Condition: (IMM.r2)
[MainAutoCountry] What is your country of origin?
Condition: (IMM.r2)
[PAYS] What is your country of origin?
Condition: (IMM.r2)
[SCOL] What is the highest level of formal education that you have completed?
SELECT ONE ONLY
Row:
[OCCUP] Which of the following categories best describes your current employment status? Are you...
SELECT ONE ONLY
Row:
[OCCUP2] Are you a healthcare provider (such as nurse, medical doctor, paramedic, first responder, pharmacist, etc.) and/or a frontline worker or essential worker (such as gas station attendant, bus driver, grocery store clerk, media worker, laboratory worker, etc.)?
Condition: False
Row:
[REVEN] Which of the following categories best describes your total household income? That is, the total income of all persons in your household combined, before taxes?
SELECT ONE ONLY
Row:
[HH_SIZE] How many people, including yourself, are supported by your total household income?
[FSA] Please indicate the first 3 characters of your postal code.
If you would rather not provide it, please select I don't know/I prefer not to answer
Thank you for agreeing to take part in this survey. We anticipate that the survey will take approximately 12 minutes to complete.
Background information
This research is being conducted by Léger Marketing, a Canadian public opinion research firm on behalf of Health Canada.
The purpose of this online survey is to collect opinions and feedback from Canadians that will be used by Health Canada to help inform government actions and decisions.
How does the online survey work? You are being asked to offer your opinions and experiences through an online survey. You have to be 18 or over in order to participate in this survey. We anticipate that the survey will take 12 minutes to complete. Your participation in the survey is completely voluntary. Your responses are confidential and will only ever be reported in aggregate – never in any way that can identify any individual respondent or their responses. Your decision on whether or not to participate will not affect any dealings you may have with the Government of Canada. What about your personal information? The personal information you provide to Health Canada is governed in accordance with the Privacy Act and is being collected under the authority of section 4 of the Department of Health Act in accordance with the Treasury Board Directive on Privacy Practices. We only collect the information we need to conduct the research project. Purpose of collection: We require your personal information such as demographic information to better understand the topic of the research. However, your responses are always combined with the responses of others for analysis and reporting; you will never be identified. Your rights under the Privacy Act: In addition to protecting your personal information, the Privacy Act gives you the right to request access to and correction of your personal information. For more information about these rights, or about our privacy practices, please contact Health Canada's Privacy Coordinator at 613-948-1219 or privacy-vie.privee@hc-sc.gc.ca. You also have the right to file a complaint with the Privacy Commissioner of Canada if you think your personal information has been handled improperly.
If you are experiencing technical issues while responding to the survey, please contact Leger's technical support team at support@legeropinion.com.
Your help is greatly appreciated, and we look forward to receiving your feedback.
[GDR] What is your gender identity?
Gender refers to current gender which may be different from sex assigned at birth and may be different from what is indicated on legal documents.
Row:
[PROV] In which province or territory do you currently live?
Row:
[YEAR] In what year and month were you born?
[AGE2] Would you be willing to indicate in which of the following age categories you belong?
Condition: (AGERef.r1)
Row:
[ETHNIC] Do you identify as any of the following?
Select all that apply
Row:
[CHILD] Are you the parent or guardian of a child or children under 18 years of age living in your household?
Row:
[CHILD_AGE] How old is/are the child/children?
Condition: (CHILD.r1)
Select all that apply
Row:
[Q89] Have you ever been infected with COVID-19?
Row:
[Q90] Do you know people in your immediate social network (i.e., friends or close family members) who have been infected with COVID-19?
Row:
[Q130] Do you consider yourself to be at risk of more severe disease or outcomes from COVID-19 (e.g., are an older adult over age 60, are pregnant, have Down syndrome, have a chronic medical condition, are immunocompromised, or live with obesity, etc.)?
Row:
[Q1] What is your most pressing concern at this time?
Select only one.
Row:
[Q3C] How would you rate your overall mental health?
Row:
[Q108] Please indicate your level of agreement with the following statement: I feel I have adequate access to mental health support services.
Row:
[Q4] In the past month, have you received any support for your mental health?
Row:
[Q4B] What type of support have your received?
Condition: (Q4.r1)
Select all that apply.
Row:
[Q4C] Why have you not received any support for your mental health?
Condition: (Q4.r2)
Row:
[Q10] When thinking about life after COVID-19, what makes you feel worried?
Select all that apply
Row:
[Q131] To what extent do you agree with the following statements?
Column:
Row:
Row:
[Q132B] Have you received a COVID-19 booster dose?
Row:
[Q92] How likely are you to get the booster dose of the COVID-19 vaccine?
Condition: (Q132B.r3)
Row:
[Q92B] How likely are you to get another booster dose of the COVID-19 vaccine?
Condition: (Q132B.r1 or Q132B.r2)
Row:
[Q93] What is the top reason you are unlikely or uncertain about getting a booster dose?
Condition: (Q92.r3 or Q92.r4 or Q92.r98) or (Q92B.r3 or Q92B.r4 or Q92B.r98)
Row:
[Q76] Amongst the following factors and thinking about the current COVID context, what would motivate you to get your booster dose?
Condition: (Q132B.r3)
Please select up to your top 3
Row:
[Q133] If recommended, how likely would you be to get a COVID vaccine at the same time as a flu shot?
Condition: (Q92.r1 or Q92.r2) or (Q92B.r1 or Q92B.r2)
Row:
[Q134] If COVID-19 vaccines were offered as a routine vaccine (e.g. annually), how likely would you be to get one?
Row:
[Q134B] What is the top reason you are unlikely or uncertain about getting a routine COVID-19 vaccine?
Condition: (Q134.r3 or Q134.r4 or Q134.r98)
Row:
[Q135] Thinking about your child(ren) aged 12-17, how many doses of a COVID-19 vaccine have they received?
Condition: (CHILD_AGE.r4)
Select all that apply
Row:
[Q95] Thinking about your child(ren) aged 12-17, how likely are you to have them receive a booster dose of the COVID-19 vaccine?
Condition: (Q135.r1 or Q135.r2)
Row:
[Q136] Thinking about your child(ren) aged 5-11, how many doses of a COVID-19 vaccine have they received?
Condition: (CHILD_AGE.r3)
Select all that apply
Row:
[Q136B] Thinking about your child(ren) aged 5-11, how likely are you to have them receive a booster dose of the COVID-19 vaccine?
Condition: (Q136.r1 or Q136.r2 or Q136.r6)
Row:
[Q110] Why are you not likely or not sure to have your child(ren) get a booster dose of a COVID-19 vaccine?
Condition: (Q95.r3 or Q95.r4 or Q95.r98) or (Q136B.r4 or Q136B.r98)
Select up to 3 reasons.
Row:
[Q98] Thinking about your child(ren) between 6 months and under 5, if a COVID-19 vaccine becomes available to your child/children, would you choose to get your child(ren) under 5 vaccinated?
Condition: (CHILD_AGE.r1 or CHILD_AGE.r2)
Row:
[Q28] Which of the following factors would make you more likely to vaccinate your child(ren) against COVID-19?
Condition: (Q98.r2 or Q98.r3 or Q98.r98)
Please choose your top three.
Row:
[Q111] Have any of your child's regular childhood vaccinations been missed/delayed as a result of the pandemic?
Childhood vaccinations are defined as routine vaccines given in childhood to protect against serious diseases such as diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type B (Hib), rotavirus, hepatitis B, measles, mumps, rubella, chickenpox, pneumococcal and meningococcal diseases, and human papillomavirus virus (HPV).
Row:
[Q112] Do you intend to catch up on your child's missed/delayed regular childhood vaccinations?
Condition: (Q111.r1)
Row:
[Q137] Why do you not plan for your children to get the recommended childhood vaccines?
Condition: (Q112.r2)
Row:
[Q138] Adult routine vaccinations are defined as routine vaccines and/or boosters given in adulthood to protect against serious diseases such as shingles (recommended for 50+), tetanus, pertussis (whooping cough), influenza (flu) and pneumococcal (recommended for 18+ with chronic medical conditions and healthy adults aged 65+). Have you missed/delayed any routine vaccinations as a result of the pandemic?
Row:
[Q139] Do you intend to catch up on your missed/delayed routine vaccinations?
Condition: (Q138.r1)
Row:
[Q140] Why do you not intend to catch up on your missed/delayed routine vaccinations?
Condition: (Q139.r2)
Row:
[Q142] Has the recent COVID-19 pandemic had an impact on your confidence in vaccinations in general?
Row:
[Q143] Why are you less confident in vaccinations?
Condition: (Q142.r1 or Q142.r2)
Select all that apply
Row:
[Q144] Do you intend to get the flu vaccine this year?
Row:
[Q145] Why do you not intend to get your flu shot this year?
Condition: (Q144.r2 or Q144.r98)
Select all that apply
Row:
[Q1B] How often do you follow each of the following public health measures?
Individual public health measures are actions you can use every day to help reduce the spread of COVID-19 and other respiratory infectious diseases. These measures are also sometimes referred to as personal preventive practices. Examples include: wearing a mask, staying home when sick, improving indoor ventilation, practicing respiratory etiquette and hand hygiene and cleaning and disinfecting high-touch surfaces.
NOTE: In any questions below that refer to masks, the word mask refers to a non-medical mask, medical mask or respirator (eg: N95 or KN95).
Column:
Row:
[Q115] Many individual public health measures (e.g., staying home when sick, handwashing, mask-wearing) were recommended in 2020 to help control the spread of COVID-19. How much do you think these individual public health measures could help reduce the spread of other respiratory infectious diseases, such as seasonal influenza (the flu)?
Row:
[Q146] What is the top reason you rarely or never practice any individual public health measures to reduce the spread of other respiratory diseases?
Condition: (Q1B.r3.c4 or Q1B.r3.c5) or (Q1B.r7.c4 or Q1B.r7.c5) or (Q1B.r8.c4 or Q1B.r8.c5) or (Q1B.r9.c4 or Q1B.r9.c5) or (Q1B.r10.c4 or Q1B.r10.c5) or (Q1B.r11.c4 or Q1B.r11.c5)
Row:
[Q147] How confident, if at all, do you feel about making your own decisions with respect to choosing to practice any or all of the individual public health measures mentioned in the previous questions (i.e. wearing a mask etc)?
Row:
[Q148] Which of the following would be useful to help your decision making about using any or all of the individual public health measures mentioned in the previous question (i.e. wearing a mask etc)?
Select all that apply.
Row:
[Q149] Where would you go for these types of information?
Condition: (Q148.r1 or Q148.r2 or Q148.r3 or Q148.r4)
Select all that apply.
Row:
[Q150] To what extent do you feel pressured by others to practice or not practice individual public health measures?
Row:
[Q151] How familiar are you with the potential long-term effects of having COVID-19 (also known as "long-COVID" or "post COVID-19 condition")?
Row:
[Q152] How worried are you/would you be about developing longer-term symptoms from a COVID-19 infection?
Row:
[Q153] What makes/would make you feel worried about long-term symptoms of COVID?
Condition: (Q152.r1 or Q152.r2)
Select all that apply.
Row:
The last few questions are strictly for statistical purposes. All of your answers are completely confidential.
[LANGU] What is the language you first learned at home as a child and still understand?
Row:
[MINO] Do you identify as any of the following?
SELECT ALL THAT APPLY
Row:
[IMM] Where were you born?
Row:
[YIMM] In what year did you move to Canada?
Condition: (IMM.r2)
[MainAutoCountry] What is your country of origin?
Condition: (IMM.r2)
[PAYS] What is your country of origin?
Condition: (IMM.r2)
[SCOL] What is the highest level of formal education that you have completed?
SELECT ONE ONLY
Row:
[OCCUP] Which of the following categories best describes your current employment status? Are you...
SELECT ONE ONLY
Row:
[OCCUP2] Are you a healthcare provider (such as nurse, medical doctor, paramedic, first responder, pharmacist, etc.) and/or a frontline worker or essential worker (such as gas station attendant, bus driver, grocery store clerk, media worker, laboratory worker, etc.)?
Condition: False
Row:
[REVEN] Which of the following categories best describes your total household income? That is, the total income of all persons in your household combined, before taxes?
SELECT ONE ONLY
Row:
[HH_SIZE] How many people, including yourself, are supported by your total household income?
[FSA] Please indicate the first 3 characters of your postal code.
If you would rather not provide it, please select I don't know/I prefer not to answer
PROJECT DESCRIPTION
The groups will be held online via CMNTY.
8 groups in total: three groups in French (3): Quebec and New-Brunswick and five (5) group in English: Ontario, BC, Prairies and territories.
The objective is to have 8-10 participants per focus group (recruits 12 per group).
DATE / TIME |
PARTICIPANTS |
|
---|---|---|
GROUP 1 8-10 participants |
June 20, 2022, 5pm |
Group with Young adults (English, Ontario)
|
GROUP 2 8-10 participants |
June 20, 2022, 7pm |
Group with Young adults (English, BC, Prairies, Territories)
|
GROUP 3 8-10 participants |
June 20, 2022, 5pm |
Group with Young adults (French, Qc, NB)
|
GROUP 4 8-10 participants |
June 21, 2022, 5pm |
Group with Adults 35-60 (English, BC, Prairies, Territories)
|
GROUP 5 8-10 participants |
June 21, 2022, 7pm |
Group with Adults 35-60 (English, Ontario)
|
GROUP 6 8-10 participants |
June 20, 2022, 7pm |
Group with Adults 35-60 (French, Qc, NB)
|
GROUP 7 8-10 participants |
June 22, 2022, 5pm |
Group with parents (English, BC, Prairies, Ontario)
|
GROUP 8 8-10 participants |
June 21, 2022, 5pm |
Group with parents (French, Qc, NB)
|
Indigenous participants and participants from different ethnic communities will be recruited. There will be at least one participant from a different ethnic community in each group. Leger will also try to recruit three indigenous respondents that will be distributed among the eight groups.
For each participant, collect the following information:
Participant name:
Phone number at home:
Cell phone:
Email address:
Recruitment date:
Recruiter :
Group #:
Confirmation (date):
INTRODUCTION
Hello/Bonjour, I'm (name) of Leger, a marketing research company. We are organizing a research project on behalf of Health Canada. The research's objective is to collect opinions and feedback from Canadians that will be used by Health Canada to understand Canadians' behaviours and attitudes with respect to COVID-19.
We are preparing to hold a few research sessions with people like yourself. Participation is completely voluntary. We are interested in your opinions. The format is an "online" discussion led by a research professional with up to ten participants. All opinions will remain anonymous and will be used for research purposes only in accordance with laws designed to protect your privacy. You don't need to be an expert to participate. We don't have anything to sell and we don't advertise and it's not an opinion poll on current events or politics. We are organizing several of these discussions. We would be interested in possibly having you participate.
Your participation is voluntary. All information collected, used and/or disclosed will be used for research purposes only and the research is entirely confidential. We are also committed to protecting the privacy of all participants. The names of the participants will not be provided to any third party. May I continue?
[INTERVIEWER NOTE: IF ASKED ABOUT PRIVACY LAWS, SAY: "The information collected through the research is subject to the provisions of the Privacy Act, the legislation of the Government of Canada, and to the provisions of relevant provincial privacy legislation.]
The focus group would take place online on the (INSERT DATE/TIME) and will be a maximum of 2 hours. You will be compensated $135 for your time.
I repeat that participation is entirely voluntary, and all information you provide is completely confidential. The full names of participants will not be provided to any third party.
A1. Are you interested in participating?
Yes |
1 |
CONTINUE |
No |
2 |
THANK AND CONCLUDE |
I would now like to ask you a few questions to see if you meet our eligibility criteria to participate.
When you conclude, say: Thank you for your cooperation. We have already reached the number of participants with a profile similar to yours. Therefore, we cannot invite you to participate.
A2. The group discussions we are organizing are going to be held over the Internet. They are going to be "online focus groups". Participants will need to have a computer, a high-speed Internet connection, and a WebCam in order to participate in the group. Would you be able to participate under these conditions?
Yes |
1 |
CONTINUE |
No |
2 |
THANK AND CONCLUDE |
PROFILING
INTRO1.
Do you or anyone in your immediate family work or have you ever worked in...?
Marketing Research |
1 THANK AND CONCLUDE |
Marketing and Advertising |
2 THANK AND CONCLUDE |
Public relations, communications |
3 THANK AND CONCLUDE |
Media (newspapers, television, radio, etc.) |
4 THANK AND CONCLUDE |
Telecommunications |
5 THANK AND CONCLUDE |
None of the above |
9 |
Gender
Please indicate the gender of the person.
Male |
1 |
Female |
2 |
Other |
3 |
Gender: Ensure a good mix during the recruitment, Other is not a screening criteria
Province
In which province or territory do you live?
British Columbia |
1 |
Alberta |
2 |
Saskatchewan |
3 |
Manitoba |
4 |
Ontario |
5 |
Quebec |
6 |
New Brunswick |
7 |
Nova Scotia |
8 |
Prince Edward Island |
9 |
Newfoundland |
10 |
Northwest Territories |
11 |
Yukon |
12 |
Nunavut |
13 |
AREA
Which of the following best describes the area in which you live?
Urban area |
1 |
Rural area |
2 |
Language
What is your first official language spoken?
Note for recruiter if respondent asks: In Canada, 'first official language spoken' is specified within the framework of the Official Languages Act. It refers to the first official language (i.e., English or French) that is spoken by an individual.
French |
1 |
English |
2 |
LANGU2
Do you speak any other languages?
Yes (please specify) |
1 |
No |
2 |
AGE.
What age category do you fall into?
18 to 24 |
1 |
25 to 34 |
2 |
35 to 44 |
3 |
45 to 54 |
4 |
55 to 60 |
5 |
60 and over |
TERMINATE |
Age: Ensure a good mix of age during the recruitment
ETHN.
What is your ethnic origin?
Caucasian (white) |
1 |
Indigenous / First Nations |
2 |
Latin American (Mexican, Chilean, Costa Rican, etc.) |
3 |
Arabic (Middle East, North Africa) |
4 |
Black (African, African-American, etc.) |
5 |
South Asian (Indian, Bangladeshi, Pakistani, Sri Lankan, etc.) |
6 |
Southeast Asian (Vietnamese, Cambodian, Malaysian, etc.) |
7 |
West Asian (Iranian, Afghan, etc.) |
8 |
Chinese |
9 |
Filipino |
10 |
Korean |
11 |
Japanese |
12 |
ETHN: There should be at least one participant from another ethnic community in each group.
VACC.
What is your vaccination status with respect to COVID-19?
Two doses and booster(s) shot(s) (three doses or more) |
1 |
Two doses |
2 |
One dose |
3 |
I am not vaccinated |
4 |
VACC. For groups 1-6, there should be a maximum of 2 participants who have received two doses and booster shots (1)
CHILD.
How many children under the age of 18 do you have?
None |
1 GO TO EDUCATION |
[ ] enter number of child/children |
GO TO CHILDB |
CHILDB.
How many children do you have in the following age categories?
Under 5 years old [ ] enter number of child/children |
1 |
5 to 11 years old [ ] enter number of child/children |
2 GO TO VACCB |
12 to 17 years old [ ] enter number of child/children |
3 GO TO VACCB |
CHILDB: For groups 7 and 8, ensure at least 3 parents with children under 5 and 3 parents with children between 5 and 11 years of age. They can be the same person if the participant has children in both categories.
VACCB.
Thinking about your [child(ren) aged 12-17/ child(ren) aged 5-11], have they received a COVID-19 vaccine?
Yes, two doses or more |
1 |
Yes, one dose |
2 |
No, my child is not vaccinated |
3 |
IF THE PARTICIPANT HAS MORE THAN ONE CHILD AT CHILDB, ASK VACCB FOR EACH CHILD
VACCB: For groups 7 and 8, ensure a good mix of parents who have had their children vaccinated and who have not had their children vaccinated
EDUCATION.
What is the highest level of education you completed?
Some high school or less |
1 |
High school diploma or equivalent |
2 |
Registered Apprenticeship or other trades certificate or diploma |
3 |
College, CEGEP or other non-university certificate or diploma |
4 |
University certificate or diploma below bachelor's level |
5 |
Bachelor's degree |
6 |
Postgraduate degree above bachelor's level |
7 |
Ensure a good mix for all groups if possible during the recruitment
OCCUP.
Which of the following categories best describes your current employment status? Are you…
Working full-time (35 or more hours per week) |
1 |
Working part-time (less than 35 hours per week) |
2 |
Self-employed |
3 |
Unemployed, but looking for work |
4 |
A student attending school full-time |
5 |
Retired |
6 |
Not in the workforce (full-time homemaker, full-time parent, or unemployed and not looking for work) |
|
Other employment status. Please specify. |
GROUP ATTRIBUTION
If Province = 5 AND Language = 2 AND Age = 1 or 2 |
Group #1 |
If Province = 1, 3, 4, 11, 12 or 13 AND Language =2 AND Age=1 or 2 |
Group #2 |
If Province = 6 or 7 AND Language = 1 AND Age = 1 or 2 |
Group #3 |
If Province = 1, 3, 4, 11, 12 or 13 AND Language =2 AND Age=3, 4 or 5 |
Group #4 |
If Province = 5 AND Language = 2 AND Age = 3, 4 or 5 |
Group #5 |
If Province = 6 or 7 AND Language = 1 AND Age = 3, 4 or 5 |
Group #6 |
If Province = 1, 3, 4 or 5 AND Language = 2 AND CHILD = yes Make sure at least 3 participants have children under 5 (CHILDB=yes) and 3 participants have children between 5 and 11 years of age and ensure a good mix in regard to child vaccination. |
Group #7 |
If Province = 6 or 7 AND Language = 1 AND CHILD = yes Make sure at least 3 participants have children under 5 (CHILDB=yes) and 3 participants have children between 5 and 11 years of age and ensure a good mix in regard to child vaccination. |
Group #8 |
Also, make sure to have at least one participant from a different ethnic community in each group:
IF ETHN=3,4,5,6,7,8,9,10,11,12 or 13= AND Language =2 |
Group #1,2,4,5 or 7 |
IF ETHN=3,4,5,6,7,8,9,10,11,12 or 13= AND Language =1 |
Group #3, 6 or 8 |
AND try to have 3 indigenous participants distributed among the eight groups:
IF ETHN=2 |
Group #1-8 |
PSPC POR1
Have you ever attended a discussion group or taken part in an interview on any topic that was arranged in advance and for which you received money for participating?
Yes |
1 |
No |
2 GO TO PSPC POR |
PSPC POR2
When did you last attend one of these discussion groups or interviews?
Within the last 6 months |
1 THANK AND CONCLUDE |
Over 6 months ago |
2 |
PSPC POR 3
Thinking about the groups or interviews that you have taken part in, what were the main topics discussed?
RECORD:
THANK/TERMINATE IF RELATED TO HEALTH, VACCINE OR COVID-19
PSPC POR4
How many discussion groups or interviews have you attended in the past 5 years?
Fewer than 5 |
1 |
Five or more |
2 THANK AND CONCLUDE |
CONCLUSION
Q1.
By participating in this focus group, you will be asked to discuss with other participants and share your opinion on various topics related to the COVID-19 pandemic, public health measure, and vaccines. Please note that you do not need to be an expert to participate. You may also be asked to read during the meeting.
How comfortable do you feel in such an environment?
Read the answer choices.
Very comfortable |
1 |
Somewhat comfortable |
2 |
Not very comfortable |
3 THANK AND CONCLUDE |
Not at all comfortable |
4 THANK AND CONCLUDE |
INVITATION
Thank you. We'd like to invite you to participate in this focus group.
We are thrilled to have you as one of our participants in this study; your profile perfectly fits the target respondent we are looking for. We would like to invite you to participate in an online focus group that will be facilitated by an experienced professional moderator and will last approximately 120 minutes. The session will take place at [XX], on [XX/XX] (date/time).
For your participation, you will receive a financial incentive of $135.
Please note that the session will be recorded. Your interview may also be observed by people who are directly working on the research study.
Just a quick reminder that the groups of discussion are going to be held over the Internet. They are going to be "online focus groups". You will need a computer, a high-speed Internet connection, and a WebCam in order to participate in the group.
INV1.
Are you still interested in participating in this research study?
Yes |
1 |
No |
2 THANK AND CONCLUDE |
The information provided by you will be kept confidential and will only be disclosed to those who are directly working on the research that is relevant to the topic of discussion.
INV2.
Representatives from Health Canada may observe the discussion, but will not have access to any of your private information. You will be asked to sign a consent form in order to participate in this research. Would you be willing to do this?
Yes |
1 |
No |
2 THANK AND CONCLUDE |
PRIVACY SECTION
Now I have a few questions that relate to privacy, your personal information and the research process. We will need your consent on a few issues that enable us to conduct our research. As I run through these questions, please feel free to ask me any questions you would like clarified.
P1) First, we will provide the online platform and session moderator with a list of respondents' names and profiles (screener responses) so that they can sign you into the group. Do we have your permission to do this? I assure you it will be kept strictly confidential.
Yes |
1 GO TO P2 |
No |
2 Read information below and P1A |
We need to provide the online platform and session moderator with the names and background of the people attending the focus group because only the individuals invited are allowed in the session and the facility and moderator must have this information for verification purposes. Please be assured that this information will be kept strictly confidential. GO TO P1A
P1a) Now that I've explained this, do I have your permission to provide your name and profiles to the online platform and moderator?
Yes |
1 GO TO P2 |
No |
2 THANK AND CONCLUDE |
P2) A recording of the group session will be produced for research purposes. The recording will only be used by the team of researchers at Léger to assist in preparing a report on the research findings.
Do you agree to be recorded for research purposes only?
Yes |
1 GO TO INVITATION |
No |
2 Read information below and P2A |
It is necessary for the research process for us to record the session as the researcher needs this material to complete the report.
P2a) Now that I've explained this, do I have your permission for recording?
Yes |
1 GO TO INVITATION |
No |
2 THANK AND CONCLUDE |
As we are only inviting a small number of people to take part, your participation is very important to us. If for some reason you are unable to participate, please call so that we can get someone to replace you. You can reach us at (insert phone number) at our office. Please ask for (name).
To ensure that the focus groups run smoothly, we remind you:
Email address :
Thank you very much for your assistance!
CONTACT INFORMATION
Someone from our company will contact you to confirm the group. Could you leave me a phone number where we can reach you in the evening as well as during the day?
Name :
Phone number:
Cell phone:
Recruited by:
Confirmed by:
BLOC 1 |
Introduction and explanation |
Length |
10 MINUTES |
WELCOME AND PRESENTATION
PRIMARY AIM
RULES OF DISCUSSION
PRESENTATION OF THE GROUP ROOM
RESULTS CONFIDENTIALITY
Do you have any questions before we get started?
INTRODUCTION OF PARTICIPANTS
BLOC 2 |
FEELINGS TOWARDS COVID NOW |
Length |
10 MINUTES |
After more than two years of the pandemic, I would like to know…
What risks does COVID-19 represent for you today?
Are you up to date with your COVID-19 vaccines?
Do you know what it means to be up to date with your vaccines?
Do you think we are now out of the COVID-19 pandemic?
PROBE: why do you think so?
Whether we are in a state of pandemic or not, do you think there is still a need to protect ourselves and/or others against COVID-19?
PROBE: why do you think so?
BLOC 3 |
VACCINE CONFIDENCE |
LENGTH |
20 MINUTES |
We will now discuss vaccines and more specifically vaccines against COVID-19.
What influenced your decision to get vaccinated or not to get vaccinated?
Did you turn to others when considering whether or not to get vaccinated against COVID-19? If so, who and how did they influence your decision?
Are you still motivated by the same reasons/factors to get vaccinated now as you may have been when COVID-19 vaccines were first made available?
Do you feel COVID-19 still poses a risk to you and others? If so, how does this impact your intention to continue to be vaccinated against COVID-19 when recommended?
How do changing public health requirements and/or restrictions (like mask mandates or capacity limits) affect your opinions about the benefits of vaccination?
What do you know about COVID-19 antiviral treatments? Does their availability affect your decision to vaccinate?
How familiar are you with the potential long-term effects of having COVID-19 (also known as "long-COVID" or "post COVID-19 condition")?
Do long-term symptoms of COVID (long COVID) affect your decision to get vaccinated?
I'm going to read you two statements. Tell me which one you relate to more and why:
In your opinion, is getting vaccinated against COVID-19 an individual decision or a contribution to the public good?
And now thinking about routine vaccinations, including the influenza (flu) vaccine…
Have the COVID-19 pandemic and vaccines impacted your views and decisions related to vaccines in general, such as the flu vaccine?
PROBE: How?
BLOC 4 |
VACCINE SAFETY AND EFFECTIVENESS |
LENGTH |
20 MINUTES |
Now thinking about the safety of COVID-19 vaccines…
With millions of people vaccinated against COVID-19 around the world over the past year and a half, is safety of the vaccine still a concern? If so, explain.
PROBE: What concerns you most - common side effects (e.g., chills, fatigue, mild fever, headache, muscle aches) immediately following the vaccine or potential long-term effects of the vaccine? Do either of these impact your likelihood to get vaccinated?
And now thinking about the effectiveness of the COVID-19 vaccine…
In your opinion, do COVID-19 vaccines prevent severe illness? Prevent infection? Or both?
In your opinion, is a vaccine that prevents serious outcomes, including hospitalization and death, but not infection, considered an "effective" vaccine?
PROBE: In your view, what is the criteria for an effective COVID-19 vaccine?
Does needing to receive booster doses have an impact on your perception of the vaccine's effectiveness?
If COVID-19 vaccines were reformulated for current and/or new variants of the virus, would you be open to receiving this COVID-19 vaccine?
BLOC 5 |
PUBLIC health measures |
length |
25 MINUTES |
We will now discuss the public health measures that were introduced at some point or another during the pandemic:
Which individual public health measures have you used?
Did you use them even when not required by government, a business, event, etc.?
What do you consider to be the benefits of using individual public health measures? When would they be good to use?
When deciding whether to use any of the individual protective measures, do you ever feel you do not have enough information to help you make these decisions, or figure out what you should do and when?
PROBE: What information would you need to make informed choices?
(If needed, examples of individual PHM include mask wearing, staying home when you are sick, respiratory etiquette, cleaning and disinfecting, ventilation, etc.)
Now thinking about masking specifically…
Now that masks are no longer systematically required, would you continue to wear them? How would you decide whether or not to wear a mask?
PROBE: What conditions or circumstances would prompt you to want to wear a mask?
PROBE: Are there any circumstances or reasons why you would not feel comfortable wearing a mask?
PROBE only if feeling judged not already mentioned: Any concerns about feeling judged for wearing a mask?
Do other people's mask-wearing behaviour affect your choice to wear a mask or not? If so, how?
And now thinking about staying at home when you are sick…
How do you approach your daily activities (e.g., work, school, gathering and/or shopping, etc.) when you have mild or moderate symptoms of a cold/flu/COVID-19 (e.g., runny nose, mild headache, sore throat)?
Which symptoms would make you more likely to stay home?
Has the pandemic affected your decisions about daily activities when you are feeling sick?
BLOC 6 |
MESSAGE TESTING |
LENGTH |
25 MINUTES |
I will now present you with different messages that you might see on social media, in advertisements, online etc. regarding vaccines against COVID-19 and booster doses. After each message, we will discuss your impressions.
In your opinion, what is the difference between the following statements?
Option 1: A booster helps protect you against severe illness.
Option 2: Staying up to date with your COVID-19 vaccine helps protect you against severe illness.
Which one has a clearer message? What is it?
Which one would continue to motivate you to get vaccinated against COVID-19? Why?
Next statement:
Staying up-to-date with your COVID-19 vaccines helps protect you from getting really sick so you can get back to activities and everyday life more quickly if you do get infected.
Is it clear? Easy to understand? Does it talk to you?
Does the message motivate you to get vaccinated?
PROBE: why or why not?
How to improve them to make them clearer and more "motivational" to get vaccinated?
Next statement:
Staying up-to-date with your COVID-19 vaccines helps reduce the strain of COVID-19 for everyone, and on the health care system.
What are you first impression of the message?
Is it clear? Easy to understand? Does it talk to you?
Does the message motivate you to get vaccinated?
PROBE: why or why not?
How to improve them to make them clearer and more "motivational" to get vaccinated?
A booster dose of mRNA vaccines offers better protection against infection and severe disease, including recent variants like Omicron, than the first set of vaccines alone.
Is it clear? Easy to understand? Does it talk to you?
PROBE: What does "better protection" mean to you?
Does the message motivate you to get vaccinated?
PROBE: why or why not?
How to improve them to make them clearer and more "motivational" to get vaccinated?
Even if you've completed your primary series, protection will decrease over time. A booster dose is important to get because it increases the immune response and helps improve protection against severe outcomes by 90% or more.
Is the message clear? Easy to understand? Does it talk to you?
Does the message motivate you to get vaccinated?
PROBE: What do you think of having stats and concrete data in this type of message? Does it help to change your opinions/intentions?
Probe: what terminology is clearer "first set of vaccines" vs "primary series"
Some preliminary findings suggest that vaccination may potentially help reduce the risk of developing post COVID-19 condition, if you are infected.
Is the message clear? Easy to understand? Does it talk to you?
Does the message motivate you to get vaccinated?
PROBE: why or why not?
How to improve them to make them clearer and more "motivational" to get vaccinated?
You should get vaccinated even if you've been previously infected or think you may have been infected. While a previous COVID-19 infection can provide some protection, up-to-date vaccination—including a booster dose―is recommended to provide longer-lasting, more effective protection against severe outcomes.
Is the message clear? Easy to understand? Does it talk to you?
Do you agree with the message?
PROBE: why or why not?
How to improve them to make them clearer and more "believable"
We all have a role to play in keeping ourselves, our families and our communities healthy.
Is the message clear? Easy to understand? Does it talk to you?
Does the message motivate you to get vaccinated?
PROBE: why or why not?
How to improve them to make them clearer and more "motivational" to get vaccinated?
BLOC 7 |
MENTAL HEALTH |
DURÉE |
5 MINUTES |
Once all questions have been discussed, ask the concluding question below
Was there a time during the pandemic that your mental health was impacted? If so, when and how?
PROBE: What actions did you take to help with your mental health? Do you feel your mental health is still impacted by the pandemic?
Do you feel anxious about the lifting of the measures?
Now that most of the measures are lifted, does this have an impact on your mental health?
Do you have any final comments you would like to add on the topics we just discussed?
CONCLUDE AND END THE MEETING.
THANK YOU VERY MUCH FOR YOUR PRECIOUS COLLABORATION!
BLOC 1 |
Introduction and explanation |
Length |
10 MINUTES |
WELCOME AND PRESENTATION
PRIMARY AIM
RULES OF DISCUSSION
PRESENTATION OF THE GROUP ROOM
RESULTS CONFIDENTIALITY
Do you have any questions before we get started?
INTRODUCTION OF PARTICIPANTS
BLOC 2 |
FEELINGS TOWARDS COVID NOW |
Length |
10 MINUTES |
After more than two years of the pandemic, I would like to know…
What risks does COVID-19 represent for you and your children today?
Are you up to date with your COVID-19 vaccines?
Do you know what it means to be up to date with your vaccines?
How many doses have you received against COVID-19?
Is/are your child(ren) vaccinated? How many doses have they received?
Do you think we are now out of the COVID-19 pandemic?
PROBE: why do you think so?
Whether we are in a state of pandemic or not, do you think there is still a need to protect ourselves and/or others against COVID-19?
PROBE: why do you think so?
BLOC 3 |
VACCINE CONFIDENCE |
LENGTH |
20 MINUTES |
We will now discuss vaccines and more specifically vaccines against COVID-19.
What influenced your decision to get your child vaccinated or not?
PROBE: Who do you wish you had heard more from? Less from?
Have you discussed the COVID-19 vaccination with your health care provider? If so, to what extent?
Do you feel COVID-19 still poses a risk to your child and others? If so, how does this impact your intention to continue to get your children vaccinated/boosted?
Do long-term symptoms of COVID (long COVID) affect your decision to get your child/children vaccinated?
Would your decision to vaccinate be different for children under five years of age, compared to children older than five years of age?
Would your decision to vaccinate be different for children who are entering/undergoing puberty?
BLOC 4 |
VACCINE SAFETY AND EFFECTIVENESS |
LENGTH |
20 MINUTES |
Now thinking about the safety of COVID-19 vaccines…
What safety concerns for your child/children do you have about the COVID-19 vaccine, if any?
PROBE: What concerns you most - common side effects (e.g., chills, fatigue, mild fever, headache, muscle aches) immediately following the vaccine or potential long-term effects of the vaccine? Do either of these impact your likelihood to get your child vaccinated?
Are you concerned about the potential long-term impacts of COVID-19 vaccines for your child/children?
PROBE: what concerns you the most?
Has the pandemic impacted your opinions on vaccines more generally?
PROBE: how?
And now thinking about the effectiveness of the COVID-19 vaccine…
In your opinion, do COVID-19 vaccines prevent severe illness? Prevent infection? Or both?
PROBE: Do you feel children have a greater immunity against infection? Does this impact your decision to vaccinate your children?
PROBE IF YES: What would motivate you to vaccinate your child(ren)?
Is a vaccine that prevents serious sickness, but not infection, considered an "effective" vaccine?
Thinking about your child(ren) aged 5-11, how likely are you to have them receive subsequent dose? And if not, why are you not likely or not sure to have your child(ren) receive subsequent dose?
Does needing to receive booster doses have an impact on your perception of the vaccine's effectiveness?
BLOC 6 |
KEEPING UP TO DATE WITH VACCINES |
LENGTH |
20 MINUTES |
Do you know which immunizations kids and teens should be getting? What about for yourself?
How do you know when and which immunizations are required? Where do you get this information?
Thinking about your child(ren)'s routine immunizations, if any are not up to date, do you intend to catch up on your child's missed/delayed routine childhood vaccinations? Why not?
Has the COVID-19 pandemic affected your views and/or intentions related to routine childhood vaccinations?
BLOC 7 |
PUBLIC health measures |
length |
20 MINUTES |
We will now discuss the public health measures that were put in place at some point or another during the pandemic:
Which individual public health measures have you used? What measures have you used to protect your children?
Did you use them even when not required by government, a business, event, etc.?
PROBE: What do you consider to be the benefits of using individual public health measures? When would they be good to use?
When deciding whether to use any of the individual protective measures, do you ever feel you do not have enough information to help you make these decisions, or figure out what you should do and when?
PROBE: What information did you need to make informed choices?
(If needed, examples of individual PHM include: mask wearing, staying home when you are sick, respiratory etiquette, cleaning and disinfecting, ventilation, etc.)
Do you think there are benefits to continuing to use individual public health measures?
Now thinking about masking specifically…
Now that masks are no longer systematically required, would you and/or your child(ren) continue to wear them?
How do you decide whether or not your child(ren) should wear a mask?
PROBE: What conditions or circumstances would prompt you or your child(ren) to want to wear a mask?
PROBE: Are there any circumstances or reasons why you or your child(ren) would not feel comfortable wearing a mask?
PROBE: Any concerns about feeling judged for wearing a mask?
What has been your child(ren)'s experience with wearing a mask or not at school in the last month?
PROBE: Do they still wear a mask or not?
Overall, how was your child's experience with wearing a mask at school when it was mandatory?
And now thinking about staying at home when your child/children are sick…
How do you approach the daily activities of your child/children (e.g., work, school, gathering and/or shopping etc.) when they have mild or moderate symptoms of a cold/flu/COVID-19 (e.g., runny nose, mild headache, sore throat)?
How has the pandemic affected your decisions about daily activities when your child/children have respiratory symptoms, as compared to the time before COVID-19 (2019 and earlier)?
Which symptoms would make you more likely to keep them home?
Overall, do you feel like public health mandates have been helpful, harmful, neither or both for your child/children?
(Public health mandates can also be called community public health mandates or restrictions e.g. the requirement to wear a mask in a public setting, closures of schools or businesses)
PROBE: Why?
PROBE: Do you feel it was necessary to prevent and limit the spread of COVID-19?
BLOC 7 |
MESSAGE TESTING |
LENGTH |
15 MINUTES |
I will now present you with different messages that you might see on social media, in advertisements, online etc. regarding vaccines against COVID-19 and booster doses. After each message, we will discuss your impressions.
In your opinion, what is the difference between the following statements?
Option 1: A booster helps protect you against severe illness.
Options 2: Staying up to date with your COVID-19 vaccine helps protect you against severe illness.
Which one has a clearer message? What is it?
Which one would continue to motivate you to get vaccinated against COVID-19? Why?
Staying up to date with your COVID-19 vaccines helps protect you from getting really sick so you can get back to activities and everyday life more quickly if you do get infected.
Is it clear? Easy to understand? Does it talk to you?
Does the message motivate you to get vaccinated?
PROBE: why or why not?
How to improve them to make them clearer and more "motivational" to get vaccinated?
Staying up-to-date with your COVID-19 vaccines helps reduce the strain of COVID-19 for everyone, and on health care system.
Is it clear? Easy to understand? Does it talk to you?
Does the message motivate you to get vaccinated?
PROBE: why or why not?
How to improve them to make them clearer and more "motivational" to get vaccinated?
A booster dose of mRNA vaccines offers better protection against infection and severe disease, including recent variants like Omicron, than the first set of vaccines alone.
Is the message clear? Easy to understand? Does it resonate with you?
Does the message motivate you to get vaccinated?
PROBE: What does "better protection" mean to you?
How to improve them to make them clearer and more "motivational" to get vaccinated?
Even if you've completed your primary series, protection will decrease over time. A booster dose is important to get because it increases the immune response and helps improve protection against severe outcomes by 90% or more.
Is the message clear? Easy to understand? Does it resonate with you?
Does the message motivate you to get vaccinated?
PROBE: What do you think of having stats and concrete data in this type of message?
Probe: what terminology is clearer "first set of vaccines" vs "primary series"
How to improve them to make them clearer and more "motivational" to get vaccinated?
Some preliminary findings suggest that vaccination may potentially help reduce the risk of developing post COVID-19 condition, if you are infected.
Is the message clear? Easy to understand? Does it talk to you?
Does the message motivate you to get vaccinated?
PROBE: why or why not?
How to improve them to make them clearer and more "motivational" to get vaccinated?
You should get vaccinated even if you've been previously infected or think you may have been infected. While a previous COVID-19 infection can provide some protection, up-to-date vaccination—including a booster dose―is recommended to provide longer-lasting, more effective protection against severe outcomes.
Is the message clear? Easy to understand? Does it talk to you?
Do you agree with the message?
PROBE: why or why not?
How to improve them to make them clearer and more "believable"
We all have a role to play in keeping ourselves, our families and our communities healthy.
Is the message clear? Easy to understand? Does it resonate with you?
Does the message motivate you to get vaccinated?
PROBE: why or why not?
How to improve them to make them clearer and more "motivational" to get vaccinated?
BLOC 8 |
PANDEMIC OUTLOOK |
DURÉE |
5 MINUTES |
Once all questions have been discussed, ask the concluding question below
Was there a time during the pandemic when you noticed a change in your child's mental health? If so, when and how?
PROBE: What actions did you take to help with their mental health? Do you feel their mental health is still impacted by the pandemic?
Is your child anxious about the lifting of the measures?
Now that most of the measures are lifted, does this have an impact on their health?
Do you have any final comments you would like to add on the topics we just discussed?
CONCLUDE AND END THE MEETING.
THANK YOU VERY MUCH FOR YOUR PRECIOUS COLLABORATION!